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RÉSUMÉ 
Contexte : Les métastases hépatiques colorectales sont la principale cause de décès liée au 
cancer du foie dans le monde. Au cours de la dernière décennie, il a été démontré que l’ablation 
par radiofréquence (RFA, pour radiofrequency ablation) est une méthode de traitement percutané 
très efficace contre ce type de métastases. Cela dit, un positionnement précis de l’embout de 
l’aiguille utilisé en RFA est essentiel afin de se départir adéquatement de la totalité des cellules 
cancéreuses. Une technologie prometteuse pour obtenir la forme et la position de l’aiguille en 
temps réel est basée sur l’utilisation de réseaux de Bragg (FBG, pour fiber Bragg grating) à titre 
de senseur de contrainte. En effet, ce type de senseurs a une vitesse d’acquisition allant jusqu’à 
20 kHz, ce qui est suffisamment rapide pour permettre des applications de guidage en temps réel.  
Méthode : Les travaux présentés au sein de ce mémoire décrivent le développement d’une 
technologie, compatible aux systèmes d’imageries par résonance magnétique (IRM), permettant 
d’effectuer le suivi de la forme de l’aiguille utilisée en RFA. Premièrement, trois fibres contenant 
une série de réseaux de Bragg ont été collées dans une géométrie spécifique et intégrées à 
l’intérieur d’une aiguille 20G-150 mm. Ensuite, un algorithme de reconstruction de forme 
tridimensionnelle a été développé, basé sur les mesures de translation spectrales des FBGs 
acquises en temps réel durant le guidage de l’aiguille. La position du bout de l’aiguille ainsi que 
la forme tridimensionnelle complète de celle-ci ont été représentées et comparées à la position de 
la zone ciblée à la suite d’une simple méthode de calibration. Finalement, nous avons validé notre 
système de navigation en effectuant une série d’expériences in vitro. La précision du système de 
reconstruction tridimensionnelle de la forme et de l’orientation de l’aiguille a été évaluée en 
utilisant deux caméras positionnées perpendiculairement de manière à connaitre la position de 
l’aiguille dans le système d’axes du laboratoire. L’évaluation de la précision au bout de l’aiguille 
a quant à elle été faite en utilisant des fantômes précisément conçus à cet effet. Finalement, des 
interventions guidées en IRM ont été testées et comparées au système de navigation 
électromagnétique NDI Aurora (EMTS, pour Electromagnétic tracking system) par le biais du 
FRE (fiducial registration error) et du TRE (target registration error). 
Résultats: Lors de nos premières expériences in vitro, la précision obtenue quant à la position du 
bout de l’aiguille était de 0,96 mm pour une déflexion allant jusqu’à ±10,68 mm. À titre 
comparatif, le système d’Aurora a une précision de 0.84 mm dans des circonstances similaires. 
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Les résultats obtenus lors de nos seconds tests ont démontré que l’erreur entre la position réelle 
du bout de l’aiguille et la position fournie par notre système de reconstruction de forme est de 
1,04 mm, alors qu’elle est de 0,82 mm pour le EMTS d’Aurora. Pour ce qui est de notre 
dispositif, cette erreur est proportionnelle à l’amplitude de déflexion de l’aiguille, contrairement à 
l’EMTS pour qui l’erreur demeure relativement constante. La dernière expérience a été effectuée 
à l’aide d’un fantôme en gélatine, pour laquelle nous avons obtenu un TRE de 1,19 mm pour 
notre système basé sur les FBG et de 1.06 mm pour le système de navigation par senseurs 
électromagnétiques (EMTS). Les résultats démontrent que l’évaluation du FRE est similaire pour 
les deux approches. De plus, l’information fournie par les caméras permet d’estimer la précision 
de notre dispositif en tout point le long de l’aiguille.  
Conclusion : En analysant et en interprétant les résultats obtenus lors de nos expériences in vitro, 
nous pouvons conclure que la précision de notre système de navigation basé sur les FBG est bien 
adaptée pour l’évaluation de la position du bout et la forme de l’aiguille lors d’interventions RFA 
des tumeurs du foie. La précision de notre système de navigation est fortement comparable avec 
celle du système basé sur des senseurs électromagnétiques commercialisé par Aurora. L’erreur 
obtenue par notre système est attribuable à un mauvais alignement des réseaux de Bragg par 
rapport au plan associé à la région sensorielle et aussi à la différence entre le diamètre des fibres 
et celui de la paroi interne de l’aiguille. 
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ABSTRACT 
Background: Colorectal liver metastasis is the leading cause of liver cancer death in the world. 
In the past decade, radiofrequency ablation (RFA) has proven to be an effective percutaneous 
treatment modality for the treatment of metastatic hepatic cancer. Accurate needle tip placement 
is essential for RFA of liver tumors. A promising technology to obtain the real-time information 
of the shape of the needle is by using fiber Bragg grating (FBG) sensors at high frequencies (up 
to 20 kHz).  
Methods: In this thesis work, we developed an MR-compatible needle tracking technology 
designed for RFA procedures in liver cancer. At first, three fibers each containing a series of 
FBGs were glued together and integrated inside a 20G-150 mm needle. Then a three-dimensional 
needle shape reconstruction algorithm was developed, based on the FBG measurements collected 
in real-time during needle guidance. The tip position and shape of the reconstructed 3D needle 
model were represented with respect to the target defined in the image space by performing a 
fiducial-based registration. Finally, we validated our FBG-based needle navigation by doing a 
series of in-vitro experiments. The shape of the 3D reconstructed needle was compared to 
measurements obtained from camera images. In addition, the needle tip accuracy was assessed on 
the ground-truth phantoms. Finally, MRI guided intervention was tested and compared to an NDI 
Aurora EM tracking system (EMTS) in terms of fiducial registration error (FRE) and target 
registration error (TRE).  
Results: In our first in-vitro experiment, the tip tracking accuracy of our FBG tracking system 
was of 0.96 mm for the maximum tip deflection of up to ±10.68 mm, while the tip tracking 
accuracy of the Aurora system for the similar test was 0.84 mm. Results obtained from the 
second in-vitro experiment demonstrated tip tracking accuracy of 1.04 mm and 0.82 mm for our 
FBG tracking system and Aurora EMTS, respectively for the maximum tip deflection of up to 
±16.83 mm. The tip tracking error in the developed FBG-based system reduced linearly with 
decreasing tip deflection, while the error was similar but randomly varying for the EMTS. The 
last experiment was done with a gel phantom, yielding a TRE of 1.19 mm and 1.06 mm for the 
FBG and EM tracking, respectively. Results showed that across all experiments, the computed 
FRE of both tracking systems was similar. Moreover, actual shape information obtained from the 
camera images ensured the shape accuracy of our FBG-based needle shape model. 
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Conclusion: By analyzing and interpreting the results obtained from the in-vitro experiments, we 
conclude that the accuracy of our FBG-based tracking system is suitable for needle tip detection 
in RFA of liver tumors. The accuracy of our tracking system is nearly comparable to that of the 
Aurora EMTS. The error given by our tracking system is attributed to the misalignment of the 
FBG sensors in a single axial plane and also to the gap between the needle's inner wall and the 
fibers inside. 
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CHAPTER 1 INTRODUCTION 
1.1 Malignancy of the liver 
The liver is a vital organ which is at the core of our metabolism and performs various important 
functions. Cancers may arise from the liver itself or more commonly, spread to the liver from 
other parts of the body. As venous blood from the intestine must pass through the liver, colon 
cancers are by far the most common type of cancerous lesions of the liver. Colorectal cancer 
(CRC) is the leading cause of cancer death in the world, causing over 600,000 deaths per year 
[1]. Approximately 1.2 million new cases of CRC are diagnosed each year [1]. In Canada, one in 
fourteen males and one in sixteen females are expected to develop CRC in the course of their 
lifetime [2]. An alarming increase by 79% by the year 2030, has been predicted [3]. About 20% 
of CRC cases have liver metastasis (CRLM) at the time of diagnosis and about 50% will develop 
them during the course of the disease. The incidence of primary liver cancer (mostly 
hepatocellular cancer, HCC) has also increased worldwide over the last several decades. HCC 
results in one million deaths worldwide per year. Thus, liver cancer is a very significant clinical 
problem. Involvement of liver from any cancer usually means the disease is in an advanced stage 
with a poor prognosis. If left untreated, survival in these cases is usually up to 6-12 months [4]. 
 Generally speaking, treatment of these CRLM and HCC lesions depends on the type, 
location and stage of cancer, reserve of liver function and normal parenchyma, and patient overall 
health.  Resection of the liver lesion(s) along with resection of the primary colon tumor is the 
only potentially curative treatment for metastatic CRC. Unfortunately, only about 10% of the 
CRC patients with liver metastases are eligible for this type of curative surgery. The large size of 
the primary colon or liver lesion, extensive local spread of the primary colon cancer, multifocal 
tumors involving various segments of liver, underlying liver disease and other comorbidities 
usually render most of the patients surgically unfit. If the liver lesion(s) cannot be resected but the 
patient is otherwise a candidate for surgery, liver transplantation can be the next curative option. 
Unfortunately, there is a long waiting time for liver transplantation due to the shortage of donor 
livers. Furthermore, most patients do not meet the stringent criteria for liver transplantation and 
neither can have resection. In lieu of resection, various palliative treatments are used ranging 
from local ablation, regional chemotherapy and local radiotherapy to systemic chemotherapy. 
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While these therapies are mostly for disease control (not curative) and for prevention or treatment 
of complications, they are increasingly being used to keep the current transplant candidates 
eligible by reducing tumor burden and preserving healthy liver tissue. In some cases, successful 
locoregional therapies may render an otherwise non-transplant candidate eligible for a liver 
transplant. 
1.2 Percutaneous liver cancer treatments 
Ablation of liver tumor is possible by targeted delivery of a lethal dose of various types of 
chemicals (alcohol or acetic acid) or energy (heat, microwave, laser). Various devices and 
methods are available to perform hepatic tumor ablation during laparotomy or laparoscopy but 
also through percutaneous interventional radiology procedures. In recent years, radiofrequency 
ablation (RFA) has emerged as the most widely used tumor ablative technique for the treatment 
of CRLM and HCC [5]. It is effective, relatively safe, cheap and can be performed as an 
outpatient procedure. Under ultrasound (US) guidance a needle or electrode is placed in the 
center of the lesion. When RF energy is transmitted to the lesion through the electrode, mobile 
ions in the surrounding tissue attempt to travel in the alternating directions of the electric field. 
The movement of these ions raises the temperature (>60°C) causing tissue damage and cancer 
cell death.  RFA is used to treat small lesions having a diameter less than 3.5 cm. 
During a typical RFA procedure to ablate a liver cancer lesion, real-time ultrasound (US) is used 
to guide a needle as close as possible to the target tumor that was previously identified in 
computed tomography (CT) and/or magnetic resonance (MR) diagnostic imaging. However, in 
many cases, US cannot show the tumors that were visible in CT or MR for various reasons [6, 7]. 
Also, during thermal ablation, microbubbles are formed that appear as hyperechoic artifacts with 
shadows in US images, limiting the visibility significantly, requiring multiple needle insertions. 
To overcome these problems, multimodal image fusion (to localize the lesions exactly based on 
registration data from different image techniques, like CT, MR and US) and various needle 
tracking technologies (usually, electromagnetic or optical) are utilized to track the position of the 
needle tip in real-time. However, electromagnetic (EM) tracking suffers from interference caused 
by electromagnetic induction of nearby ferromagnetic materials such as a metallic operation table 
or any metallic medical diagnostic devices.  EM tracking is also incompatible with MR-guided 
interventions because of the magnetic field interference between the local field generator and the 
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MR magnet [8]. In the case of optical tracking, the "straight line of sight" requirement limits 
tracking to the tip of a bent needle [9]. In actuality, precise needle tip placement becomes further 
challenging due to needle tip deflection caused by needle asymmetry (beveled tip) and due to 
inhomogeneities in the liver tissue, especially with increasing insertion depth and needle length 
[10]. Without precise positioning of the needle tip into the center of the target lesion, adequate 
energy is not delivered to ablate the tumor and adjacent healthy tissue is damaged. Therefore, it is 
essential to correctly track the needle in real-time for successful delivery of radiofrequency 
energy. An alternative tracking technology free of limitations of EM or optical tracking, yet MR 
compitable, is needed. 
A promising technology to obtain real-time information of the needle shape is by using fiber 
Bragg grating (FBG) sensors. An FBG sensor is a type of distributed Bragg reflector constructed 
inside the core of a glass fiber that reflects one specific wavelength and transmits all others. 
These miniature FBGs are immune to electromagnetic interference and are capable of accurately 
sensing even submicron displacement. They are also able to provide read-out at a high sampling 
rate (>20 kHz), which is important for real-time tracking of a medical device. By placing a series 
of FBGs along the ablation needle and reading each of them via optical multiplexing, it is 
possible to retrieve precise, real-time data of the fiber inside the needle. Thus, the 3D shape of the 
entire needle can be reconstructed by using the MR-compatible FBG sensor measurements that 
could safely track the needle in real time and in a strong electromagnetic field during MRI-guided 
interventions on liver tumors, satisfying the main objective of this study. 
1.3 Research objectives 
In this research project, the global objective was to develop an MR-compatible needle tracking 
technology designed for RFA procedures in liver cancer. Towards this end, the 3D shape 
reconstruction of a flexible needle using FBG sensor measurements was studied. The specific 
objectives of the project were as follows: 
(i) Construction of the needle tracking device: Three optic fibers each containing a series of 
FBGs, were glued together so that the FBG sensors across the fibers were aligned and 
oriented in 120° to each other. Then, we integrated these three fibers inside a 20G-150 
mm needle.  
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(ii) Development of 3D shape reconstruction algorithm: Once the needle prototype was 
fabricated, we developed a three-dimensional needle shape reconstruction algorithm 
based on the FBG measurements collected in real-time during needle guidance.  
(iii) Implementation of a navigation software: In addition, to infer the position and 3D shape 
of the needle in real-time during the RFA procedure, it is important to visualize the 
needle’s position and shape with respect to the internal anatomy of the patient based on a 
prior CT or MRI imaging. So, the next step was to perform a fiducial-based registration 
(FBR), by identifying markers on the patient in order to register the FBG tracking space 
with the image space of the preoperative MRI and to visualize the needle in the image 
space. actual shape information obtained from the 
(iv) In-vitro validation: Finally, we validated FBG-based needle navigation by doing a series 
of in-vitro experiments. The shape of the 3D reconstructed needle was compared to the 
measured shape information of the needle obtained from camera images. Needle tip 
tracking accuracy was also assessed on a ground-truth phantom. Lastly, MRI guided 
tracking was tested and compared to EM tracking system (EMTS) in terms of fiducial 
registration error (FRE) and target registration error (TRE). 
1.4 Thesis structure 
The remainder of this thesis is organized as follows. Chapter 2 presents background information 
related to this project such as the etiology of liver cancer and various treatment techniques 
available. Various ablation therapies for CRLM and HCC as well as their individual pros and 
cons and corresponding mortality and morbidity outcomes are described. Chapter 3 gives an 
overview of tracking technologies for image guided liver interventions, describes needle tracking 
techniques under MRI guidance and provides a literature review of optical shape sensing 
technology. Chapter 4 first describes needle fabrication and FBG calibration processes followed 
by the methodology for reconstructing the shape of the needle in 3D. This chapter also shows the 
steps needed to generate various synthetic phantoms used for this project. The results of all the 
in-vitro experiments with our FBG-based tracking system are presented in Chapter 5. The results 
obtained from the NDI Aurora system for similar experiments are also demonstrated for 
comparison. The experimental results are discussed and analyzed in Chapter 6 along with the 
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limitations of our developed system. Finally, Chapter 7 summarizes the project and proposes 
future extensions. 
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CHAPTER 2 BACKGROUND 
This section presents the background related to this research project. First, the anatomy of the 
liver, primary (hepatocellular carcinoma, HCC) and secondary (or metastatic) malignant tumors 
of the liver will be briefly described. Various treatments of CRLM and HCC such as surgical 
resection, liver transplantation and different types of locoregional therapies will be presented next 
along with their advantages and limitations. RFA will be discussed in detail along with some of 
the challenges with prior image registration and intra-procedure needle tracking.  
2.1 Liver anatomy 
The liver is the largest organ in the abdomen weighing approximately 1500 g [11]. It is located 
under the diaphragm to the right side of the abdomen, almost entirely covered the rib cage. The 
liver moves with respiration and from pulsation from blood circulation in the hepatic arteries. It 
possesses one large right lobe and a much smaller left lobe. The two other minor lobes called 
caudate and quadrate lobes, can be seen on the posterior surface. 
 
Figure 2.1: Segments of the human liver based on Couinaud segments [12]. Used with 
permission. 
The major blood vessels (portal vein and hepatic artery) after entering the liver divide into right 
and left branches and supply respective lobes of the liver. However, from a more functional-
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anatomic point (Couinaud classification) [13], the liver can be divided into eight independent 
segments (see Figure 2.1). Every segment has its individual vascular inflow (segmental portal 
vein and hepatic artery), outflow (segmental hepatic vein) and biliary drainage (biliary duct). The 
segmental anatomy is the basis for various types of anatomic liver resections. Blood enters the 
liver through the portal vein (75%) and hepatic artery (25%) [14]. The portal vein, formed by the 
union of the splenic vein and superior mesenteric vein, brings blood to the liver from the spleen 
and gastrointestinal tract. The hepatic artery is a branch of the celiac artery and provides 50% of 
the oxygenation of the organ. The hepatic artery in the liver is divided into two lobar branches, 
left and right hepatic arteries and each branch gives rise to segmental branches and further 
ramifications in the parenchyma [15]. The vascular outflow from each segment (segmental veins) 
links to form the right, middle and left hepatic veins which later merge into the inferior vena 
cava. 
2.2 Liver cancer 
Based on the origin of cancer, liver cancer can be classified into primary (originates in the liver) 
and secondary or metastatic cancer (cancer cells spread by blood from other organs, embed in the 
liver and then grow to become a mass). Among primary liver cancers, hepatocellular carcinoma 
(HCC) is the most common, while colorectal liver metastasis (CRLM) is the most common 
among the secondary liver cancers.  
2.2.1 Hepatocellular carcinoma 
Hepatocellular carcinoma (HCC) is the most common primary liver cancer [16], accounting for 
662,000 deaths worldwide each year [17]. In fact, HCC is the sixth most frequent malignancy and 
the third leading cause of cancer death worldwide [18]. It is more prevalent in sub-Saharan 
Africa, China, Japan, central and southeast Asia [18]. Chronic viral hepatitis due to hepatitis B 
and C viruses, liver cirrhosis from other causes like alcohol and obesity (non-alcoholic fatty liver 
disease), various toxins and chemicals are identified as likely reasons for HCC. Men in the age 
group of 30-50 years are affected 2-5 times more frequently than women in similar age group 
[19]. HCC usually presents at a late stage and life expectancy of non-operable cases at diagnosis 
ranges between 6 and 24 months [20]. Overall survival rates at 1-year, 3-years, and 5-years have 
been reported as 66.1%, 39.7%, and 32.5% [20]. 
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2.2.2 Metastatic liver cancer 
Cancers originating from other organs like colon, pancreas, lungs or breasts spread to the liver 
through the bloodstream and lymphatic drainage. However, the majority of liver metastases arise 
from colorectal cancer as venous blood from the intestine drains through the liver. In fact, 20% of 
CRC cases have liver metastasis at diagnosis and another 30% develop them during disease 
progression. With an annual incidence of 1.4 million of CRC worldwide, CRLM continues to be 
a severe health problem. Naturally, liver metastases are more common than primary liver cancers. 
Life expectancy without treatment is 6-12 months and the five-year survival rate is <5%. Even 
with modern chemotherapy, only <10% of patients with metastatic colon cancer who could not 
have a resection remain alive after five years. With resection of limited CRLM and primary colon 
cancer combined with chemotherapy, this can be increased to 50% [21]. 
2.3 Treatment of liver cancer 
Malignant liver lesions are treated with a variety of therapeutic modalities, which is an active 
research area by itself. Though treatments and patient selection vary from institution to institution 
and country to country, in general, surgical resections (of segments or lobes), liver 
transplantation, various types of locoregional therapies and systemic chemotherapy, alone or in 
combinations are typically used to treat HCC and CRLM. Various local treatments include: 
surgical resection of the affected part of the liver and local ablation of the tumor using different 
techniques like instillation of ethanol or acetic acid, hyperthermic coagulation using 
radiofrequency, microwave or laser, cryotherapy, transhepatic arterial chemoembolization, 
radioembolization and hepatic intra-arterial chemotherapy. These modalities may be employed 
alone or in various combinations. Resection is potentially curative in HCC and has the best 
outcome. Resection of the limited liver metastatic lesion with the removal of the primary colon 
tumor in combination with chemotherapy can be curative in CRC. Liver transplant is another 
potentially curative treatment for HCC without extrahepatic spread. Many factors like tumor size, 
number and location in liver, reserve of healthy liver tissue and function, and surgical fitness 
dictate which method is best for an individual patient. 
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2.3.1 Resection operation 
When patients are eligible for surgery, resection offers the best outcome in the treatment of HCC 
and some cases of CRC with limited CRLM. Surgical removal of primary colon lesions along 
with surgical removal of limited metastatic lesion(s) in liver combined with pre- and/post-
operative chemotherapy can be curative in >40% cases. Resection of liver metastasis also helps 
systemic chemotherapy by reducing the cancer burden. This technique involves surgically 
removing the portion of the liver harboring cancer, while carefully preserving healthy residual 
parenchyma. During a resection, up to 80% of the volume of liver can be removed. The 5-year 
survival rate of patients with isolated liver metastases from CRC treated with resection is 
between 30% and 58% [22]. However, 90% of patients with metastatic CRC are not candidates 
for surgical resection due to bilobar disease, proximity to critical structures that precludes 
complete resection, and comorbidities rendering patients unfit [23]. Due to better surgical 
techniques, this area is changing quickly and more and more patients are now offered resection 
that in the past were deemed to have unresectable tumors. Tumor recurrence after surgical 
resection is common, especially if the resected margin is positive for cancer (70% of the patients 
at five years) but also due to microvascular invasion and satellite nodules [24, 25]. Improvements 
in surgical techniques, post-resection chemotherapy and use of RFA showed promising results. 
2.3.2 Nonsurgical treatment 
Most of the patients with CRLM are unsuitable for liver resection or transplantation due to the 
extent of the disease (multiple metastases, locations), limited healthy hepatic parenchyma and 
lack of a donor. Various locoregional treatments and systemic therapies are available in this 
situation to prevent tumor progression and delay the need for systemic chemotherapy. Ablation of 
the tumor is done through intratumoral injection of chemicals, radiofrequency ablation (RFA) or 
new technologies, such as microwave or laser ablation. Cryoablation and irreversible 
electroporation are other ablative methods. Results of systemic chemotherapy (using fluorouracil, 
leucovorin, oxaliplatin, irinotecan, bevacizumab, etc.) in advanced CRC are good, where it 
(mostly sorafenib) is mostly used as a palliative therapy. 
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2.3.2.1 Ablation therapy 
Ablation is a minimally invasive treatment that applies an effective toxic or lethal dose of 
chemicals or temperature change (high or freezing temperature) on the cancerous area to kill the 
cancer cells. Ablation is done by intratumoral injection of acetic acid or ethanol, radiofrequency 
ablation (RFA) or using new technologies, such as microwave, laser, irreversible electroporation 
or cryogenics. The percutaneous route is usually preferred while lesions in the dome of the liver 
or close to the inferior liver margin are treated laparoscopically or need a laparotomy. However, 
access to the tumor is not always possible and risks of bowel perforation, ischemic liver injury, 
bleeding, and infection are present. 
2.3.2.2 Percutaneous intratumoral injection 
Percutaneous ethanol injection (PEI) generally requires repeated sessions: tumors less than 2 cm 
usually need 3 to 4 sessions, while tumors 2 to 3.5 cm are treated in 8-12 sessions. This technique 
is effective for small tumors (<3 cm) [26]. It is more efficient in treating HCC lesions than 
CRLM as HCC has a capsule, which together with the surrounding cirrhotic liver tissue prevents 
dissemination of the alcohol or acetic acid. Complications of PEI were addressed in a report of 
270 patients with small liver tumors (≤2 cm) where the major complication rate was only 2.2% 
and no mortality was reported [27]. 
2.3.2.3 Microwave ablation (MWA) 
In the case of microwave ablation (MWA), a thin microwave antenna is placed percutaneously 
directly into the tumor to deliver electromagnetic microwave energy. The microwaves create an 
agitation of water molecules inside or near the tumor regions, causing friction that generates heat 
leading to cancer cell death via coagulation necrosis. The main advantages of MWA over other 
thermal ablation techniques are: 1) increased stability in higher intratumoral temperature, 2) 
ability to ablate larger tumor volumes, 3) quicker ablation times, and 4) improved convection 
profile to cover the tumor [28]. Most of the data are from Asian countries and recent studies 
demonstrated complication rates of 14.2 to 20.6% [29]. A study of 94 RFA treatments for 224 
lesions in 87 patients reported overall mortality rate of 2.3% [30].  
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2.3.2.4 Cryoablation 
This technique involves inserting cooled thermally conductive fluids, such as liquid nitrogen and 
argon gas, into the tumor through cryoprobes to freeze the tumor cells. The main drawback with 
cryoablation is that it requires laparotomy. Cryoshock has a reported mortality of 8% [31] along 
with other local complications such as hemorrhage, subphrenic abscesses, bilomas and biliary 
fistula [32], restricting its use in current clinical practice. Several studies with cryoablation 
reported high complication rate (>50%) [33] and high mortality rate (maximum of 17%) [34]. 
2.3.2.5 Radiofrequency ablation 
Radiofrequency ablation (RFA) is a popular treatment modality for unresectable hepatic tumors 
in a non-transplant candidate. It is usually performed percutaneously, by an interventional 
radiologist, as an outpatient (i.e. without being admitted to a hospital) procedure. RFA is a safe 
and effective. A typical RFA procedure involves inserting a needle inside a target liver tumor 
through the skin (percutaneously, but can also be done laparoscopically) under image (commonly 
ultrasound) guidance. Once the needle tip is inserted in the center of the cancerous lesion, 400 to 
500 KHz sinusoidal excitation is applied from the RFA source.  
 
Figure 2.2: The image presents the percutaneous radiofrequency ablation (RFA) procedure in the 
liver (image source from [35]). Used with permission. 
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Due to the RF current flow in the lesion, mobile ions in the surrounding tissue attempt to travel in 
alternating directions of the electric field. The movement of these ions (also called, "ionic 
agitation") produces heat that spreads into surrounding tissues until thermal equilibrium is 
achieved. Typically, the temperature for ablation ranges from 50° to 100°C. Above 45-50°C 
tissue damage is caused by thermal coagulation and protein denaturation while cell death occurs 
at around 60°C. 
Various types of needle electrodes have been developed that deploy an array of multiple curved 
stiff wires (diameter of 2~4 cm) in the form of an umbrella. RFA is suitable for CRLMs that are 
smaller than 3.5cm and not located close to major blood vessels [36]. However, tumors having 
diameters of ≥5 cm are unsuitable for complete ablation using the current RFA devices and 
requires multiple sessions. A meta-analysis of 1000 RFA treatments for 2140 lesions in 664 
patients showed that the number of needle insertion increases as the size of the tumor increases - 
mean number of needle insertions is 1.5, 2.3, 4.2 and 11.7 times for nodules of <2, 2.1 to 3, 3.1 to 
5, and >5 cm, respectively [37].  
Generally, the overall survival rates of patients treated with RFA at 3 and 5 years are 70-91% and 
48-77% [38], respectively which are higher than those of patients treated with other ablative 
treatments. The similar survival rates of patients at 3 and 5 years with PEI are 54% and 39% [39], 
respectively and with MWA are 72%, and 52%, respectively [40]. Even though RFA was 
primarily developed for patients who were not suitable for surgical resection, its application has 
expanded as a bridging therapy to convert nonresectable tumors to resectable ones [41]. The main 
advantages of RFA over other ablation techniques are its cost-effectiveness and its low 
complication rates. It has a local recurrence rate of 3.6-6% and procedural mortality rate of up to 
2%. The limiations are: difficulty with percutaneous access of the tumor, close proximaty (<1cm) 
of the tumor to major blood vessels rendering RFA unsuitable due to heat sink effect from rapid 
blood flow and the difficulty of assessing the extent of tissue damage. 
2.4 Summary 
This chapter highlighted the etiology of liver cancer and the various treatment techniques for 
liver cancer, particularly for CRLM. Even though surgical resection is considered as the gold 
standard to treat CRLM, unfortunately, only 10% of patients are eligible for this treatment. 
Among non-surgical treatments, RFA is accepted as the primary ablative modality due to its cost-
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effectiveness and low complication rates. The next chapter will focus on image-guidance systems 
for RFA. 
 
 
 
 
 
 
 
14 
 
CHAPTER 3 LITERATURE REVIEW 
This section begins with an overview of various tracking technologies for image guided 
interventions (IGI); In particular, image guided liver interventions (IGLI) such as thermal 
ablation of the tumor with RFA, MWA, etc. and surgical resection. Various needle tracking 
techniques under MRI guidance are also discussed. It also highlights the problems and limitations 
of the existing tracking technologies, especially in an MRI suite or operation room containing 
ferromagnetic materials. Recent applications of the optical shape sensing technology as an 
alternative tracking system to circumvent issues related to incompatibility of the MRI and 
electromagnetic tracking, are also reviewed. 
3.1 Image-guided interventions in liver tumors 
Image-guided intervention for liver tumors is challenging because of a complex anatomical 
structure and large deformation of the liver topology, as well as patient's breething and changes in 
posture. Typically, a surgical plan is performed based on the preoperative CT or MRI scans, due 
to their ability to visualize precisely the location of tumor in relation to vascular structures and 
surrounding anatomy. During intervention, this plan is transferred to the operating theater, to 
match the patient's anatomy with the corresponding structures seen in preoperative images. A 
proper alignment of the coordinate systems, commonly called “image-to-patient registration”, is 
essential to achieve precise positioning of the surgical tools in the preoperative image space. A 
soft-tissue organ such as the liver deforms significantly during surgery because of the patient 
being under the effect of anesthesia or positioned differently on the surgical table, or for 
laparoscopy due to distention of the abdomen with gas. Therefore, the surgeon cannot rely on the 
preoperative image alone to estimate the location of the tumors and related vessels under the 
surface or inside the liver. Generally, intraoperative navigation of a needle or catheter is 
facilitated by using a real-time intraoperative imaging system, such as ultrasound imaging, 
incorporating with various tracking technologies such as electromagnetic or optical systems. In 
this section, we describe the general working principles and the classification of various tracking 
systems along with their applications in IGLI and surgical resection. Challenges for each of the 
tracking systems are highlighted, which will motivate the introduction of a novel tracking 
technology. 
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3.1.1 Optical tracking system (OTS) 
In its early years, optical tracking was the most established tracking modality for IGI due to its 
relatively high accuracy over a large workspace. It is widely used in image-guided surgery to 
determine the position and orientation of line-of-sight surgical instruments. 
3.1.1.1 Working principle of OTS 
OTS includes two components: a series of cameras and markers/patterns. The working principle 
relies on triangulation. Typically a set of cameras, mounted at known positions from each other, 
capture the images of the markers attached rigidly to the surgical tools (as shown in Figure 3.1). 
The markers are segmented in the camera images and from these segmented images, the disparity 
of the markers in each frame is calculated, which then allows calculating the 3D position of the 
markers. If the 3D positions of at least three markers are known, the 3D orientation of the 
surgical tool can be computed directly. 
3D Reconstruction 
by Triangulation 
Targeted rigid body
(x y z)
markers
 
Figure 3.1: 3D reconstruction by triangulation for an optical tracking system. Image source: 
http://iotracker.com/indexdaed.html?q=optical_tracking. Used with permission. 
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3.1.1.2 Classification of OTS 
OTS can be classified into two categories: active and passive tracking. The active system (e.g. 
Northern Digital Inc., (NDI) Optotrak) uses a collection of (minimum of three) infrared light 
emitting diodes (LEDs) attached to a surgical tool in a fixed and non-symmetric fashion. LED 
markers can emit signals on their own (referring to the term “active”) to be received by cameras. 
The non-symmetric arrangement of the markers ensures correct determination of the pose of the 
surgical tools from the camera images. The active systems are typically wired, so the markers can 
be identified implicitly by activating them in a sequence. Therefore, more than one surgical tool 
having similar marker topology can be tracked. 
In contrast, passive OTS uses markers that cannot generate signals by themselves and need 
external activation to be localized (hence the term “passive”). The passive system itself can be 
divided into two further categories, one that uses retro-reflective infrared markers (e.g. NDI 
Polaris) and another that is based on visible light patterns (e.g. Claron MicronTracker). In the 
former passive system, a group of spherical retro-reflective markers is lit up when infrared light 
is emitted onto them. As a result, the markers appear as circles in the infrared camera images, 
irrespective of their orientation. However, as all the markers look identical to each other in the 
images, the topology of the markers attached to the surgical tools should be distinct from others. 
The later passive system uses known, specific patterns that have high contrast edges for robust 
segmentation. The benefit of these patterns is that they can be tracked by a stereo camera pair, 
without the assistance of infrared markers. 
Overall, the performance of the tracking system may be improved by optimizing the camera and 
marker configuration. For example, increasing the distance between the cameras increases 
fiducial registration error, while target registration error (TRE) can be reduced by increasing the 
distance between markers attached to a single surgical tool. However, a larger camera system 
also requires a larger working space and handling of larger surgical tools might be problematic 
during an intervention. Figure 3.2 shows various commercial OTS available in the market. 
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Figure 3.2: Examples of various commercial OTS with (a) active system (NDI Optotrak), passive 
system based on (b) retro-reflective infrared markers (NDI Polaris), (c) visible light patterns 
(Claron MicronTracker), (d) active markers and (e) passive markers. Image source: (a), (b), (d), 
(e) www.ndigital.com and (c) http://www.clarontech.com. Used with permission. 
3.1.1.3 Procedural steps with OTS in IGLI 
Optical tracking systems can track markers attached to a surgical tool, patient or object that needs 
to be located in real-time (as shown in Figure 3.3). For percutaneous procedures, at least, three 
markers are mounted on the needle base. Calibration of the needle is performed to determine the 
transformation between the markers and the needle tip, subsequently allowing an OTS to track 
the needle tip in real-time.  
An image-to-patient registration (typically, fiducial-based registration) is done so that the needle 
tip can be guided precisely to a selected target in the preoperative image space. During a 
registration procedure, a set of landmarks in the preoperative image is selected and the 
corresponding positions of the landmarks in patient space are retrieved by touching the markers 
with the needle tip. Finally, a verification step is performed to validate the registration accuracy 
to ensure reliable navigation of the needle. 
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Figure 3.3: Optically tracked surgical tools: (a) active probe, (b) passive probe. (image source: 
www.ndigital.com) (c) an ex-vivo experiment where optical tracking markers are attached to a 
gamma probe and phantom [42]. Used with permission. 
3.1.1.4 Studies of OTS in IGLI 
Herline et al. reported one of the earliest image-guided hepatic surgery systems in 1999. They 
developed a liver motion compensation model which they tested on a porcine liver to investigate 
the tracking accuracy of surgical tools using an OPTOTRAK 3020 OTS (NDI, Waterloo, ON, 
Canada) in open and laparoscopic surgeries [43]. Cash et al. extended this work by incorporating 
a commercially available laser range scanner (RealScan 200C; 3D Digital Corp., Sandy Hook, 
CT, USA) in open abdominal hepatic tumor resections for the liver surface registration [44]. 
Intraoperative data obtained from a laser range scanner were shown to be more robust and yield 
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accurate registration results compared to the optical tracker, as the laser scanner was capable of 
acquiring thousands of points on the liver surface [45]. 
 
Figure 3.4: Application of OTS in the operating room: (a) Polaris localizer camera used to track a 
surgical instrument in an image-guided liver resection procedure [46], (b) NDI Vicra, a passive 
OTS mounted in an operating room [47]. Used with permission. 
Lange et al. used another optical tracking system, (NDI Polaris, Waterloo, ON, Canada) for a 3D 
US based navigation system aimed at tumor resection [46] (as shown in Figure 3.4(a)). An 
intraoperative US image, obtained from a tracked 3D US probe, was matched with a preoperative 
CT image using a non-rigid registration algorithm. Another method for open surgery was 
proposed by Markert et al. [48]. Their method was based on manual registration between a 3D 
vascular model extracted from the intraoperative 3D ultrasound image and the preoperative CT-
based model. Optical sensors were attached to the US probe and were tracked by an optical 
position measurement system (NDI Vicra®, Waterloo, ON, Canada) to get the spatial orientation 
[48]. In another study, Peterhans et al. also used NDI Vicra OTS (shown in Figure 3.4(b)) to 
develop a navigation system for efficient visualization and tool guidance during surgery. Their 
simple and clinically applicable navigation system was validated on nine patients [47]. 
The studies described so far are related to open liver surgery. However, in the case of minimally 
invasive surgery (MIS), the surgeon does not have the privilege of direct visualization of the liver 
or the operating field. This limitation has motivated the development of image-guided navigation 
systems that allow effective navigation of surgical tools to the estimated tumor location 
laparoscopically. Typically, a small laparoscopic ultrasound probe, capable of generating 2D 
images, is inserted into the patient’s body through a small incision. These laparoscopic US 
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images are combined with the tracking system to improve the safety, accuracy, and outcome of 
the overall laparoscopic surgery. Lango et al. developed a navigation prototype for laparoscopic 
surgery, which could be used with an optical (e.g. NDI Polaris) or an electromagnetic (e.g. NDI 
Aurora) tracking system (Figure 3.5) [49]. Beyond the live scene obtained via the laparoscope 
alone, the surgeons benefited from the augmented laparoscopic images with the intraoperative 
ultrasound data [50]. 
 
Figure 3.5: The prototype surgical navigation system, proposed by Lango et al.; various surgical 
tools that could be tracked by the proposed system: (a) a preoperative planning pointer that could 
be used for patient registration, (b) a dedicated intraoperative laparoscopic pointer, (c) a video 
laparoscope, (d) a grasper for navigation during resection, (e) a radio frequency ablation probe, 
(f) a flexible ultrasound probe with electromagnetic tracking sensors on the tip [49]. Used with 
permission. 
Feuerstein et al. used an OTS, consisting of four optical tracking cameras (ARTtrack2, ART 
GmbH), to determine the position and orientation of both the mobile C-arm scanner and the 
laparoscope in a single coordinate system [51]. So, additional registration was not required to 
augment the intraoperative CT on the live laparoscopic video. 
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3.1.1.5 Advantages of OTS 
The main advantage of OTS is that it can offer a large working volume (as shown in Figure 3.6) 
with sub-millimeter accuracy. According to NDI, the major manufacturer of medical tracking 
systems, the positional accuracy of NDI Polaris OTS is 0.50 mm with a precision of 0.25 mm 
[52]. It is not susceptible to magnetic interference, so can be used alongside MRI or in the 
presence of other metal objects. Also, a wireless system simplifies the operation environment. 
 
Figure 3.6: Working volume offered by OTS (a) NDI Polaris and (b) NDI Vicra. (image source: 
www.ndigital.com). Used with permission. 
3.1.1.6 Disadvantages of OTS 
On the other hand, OTS requires an unobstructed line of sight between the cameras and the 
tracked instruments. This constraint limits the application of OTS tracking the instrument inside 
the patient. For example, the tip of a flexible needle that is not visible by the cameras cannot be 
tracked directly. Besides, the attachment of a set of markers to the tracked instruments often 
makes their use very cumbersome. 
3.1.2 Electromagnetic tracking system (EMTS) 
The advent of the electromagnetic tracking system (EMTS) occurred as a method of choice 
where the line of sight is blocked, since OTS is no longer a suitable option. EMTS does not 
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require a direct line of sight to its markers. As a result, its application has surged in various 
medical fields - especially in image guided interventions that utilize flexible instruments inside 
the body. 
3.1.2.1 Working principle of EMTS 
EMTS includes a field generator that produces an ultra-low magnetic field with spatially and 
temporarily variable field strength (see Figure 3.7). When an electromagnetic sensor coil is 
placed in this varying magnetic field, a weak but detectable electrical current is generated in the 
sensor coil according to Faraday’s law of electromagnetic induction. Depending on the strength 
of this induced current, the position and the orientation of the coil is defined within a Cartesian 
coordinate system defined by the field generator. Modern field generators have six or nine coils 
in a tetrahedral configuration that allows computing 5 degrees of freedom (DOF) from a single 
sensor coil (three translational and two rotational) [53]. As the size of this sensor is very small 
(less than 1 mm), two sensors can be coupled in a non-parallel manner to determine all the 6-
DOF (three translational and three rotational). 
 
Figure 3.7: EMTS working principle. An EM sensor experiences a spatially and temporarily 
varying magnetic field, produced by the field generator, that induces a current in it.   
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3.1.2.2 Classification of EMTS 
EMTS can be classified into three categories: alternating current (AC) driven, direct current (DC) 
driven and passive or transponder systems. As implied by their name, AC-driven systems use AC 
magnetic fields where inductive sensors measure the variation of the magnetic flux; DC-driven 
systems use fluxgate sensors in DC magnetic fields [54]. AC-driven EMTS are available from 
NDI Aurora (Figure 3.8a) and Polhemus Fastrak (Figure 3.8b) while Ascension miniBIRD 
(Figure 3.8c) offer DC-driven EMTS. Passive or transponder EMTS uses either small permanent 
magnets or implanted transponders. Tracking is done either by measuring the magnetic field of 
the magnets or analyzing the emitted signal properties (e.g. intensity, delay or phase shift) from 
the transponders [55]. For example, Calypso GPS for the body system, from Varian Medical 
System Inc. (Palo Alto, CA, USA), is a passive transponder based tracking technology (see 
Figure 3.8d). 
3.1.2.3 Procedural steps in image guided intervention using EMTS 
Electromagnetic tracking provides real-time tracking (refresh rate 40 Hz) of a variety of surgical 
tools by integrating miniature-size EM sensors. For instance, in image guided needle 
interventions, the tip of the needle includes a 5-DOF EM sensor that facilitates tracking the tip in 
real-time. Typically, the intervention procedure begins with the acquisition of preoperative 
images with a set of fiducial markers (e.g. skin markers). Then, to perform image-to-patient 
registration (e.g. fiducial-based registration), a set of fiducial markers in the patient space are 
chosen by touching with the needle tip and consequently, the corresponding markers are selected 
in the image space. After the registration step, the tracked needle tip can be represented in the 
same image coordinate space. Finally, the registration accuracy is verified to confirm successful 
navigation. 
24 
 
 
Figure 3.8: Magnetic field generator and sensors of different commercially available EMTS. AC-
driven (a) NDI Aurora, (b) Polhemus Fastrak; DC-driven (c) Ascension miniBIRD and (d) 
passive transponder based "Calypso GPS for the body system" from Varian Medical System Inc. 
Image source: (a) www.ndigital.com, (b) www.polhemus.com, (c) www.ascension-tech.com, (d) 
www.varian.com. Used with permission. 
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3.1.2.4 Studies related to EMTS in IGLI 
Integration of a miniature electromagnetic sensor inside a needle tip enables spatial tracking of 
needles and facilitates needle navigation in various thermal ablation procedures. Generally, in 
these procedures, preoperative CT, MRI or positron-emitting tomography (PET) images are fused 
with real-time US images, where EMTS is typically used to localize the needle or the US probe 
in the fused image space. Percutaneous biopsy and RF ablation in the liver has been performed 
under CT/US guidance [56, 57] or in combination with PET [58] or MRI [59] guidance using an 
EM tracking system.  
Some clinical studies reported needle tracking accuracy with EM navigation system for biopsy 
and RFA procedures in the liver and various other organs such as lung, spine and kidney [57, 60]. 
Krucker et al. achieved a spatial tracking error of 3.8 ± 2.3 mm in a 40-patient clinical trial [57]. 
In another study, Penzkofer et al. performed twenty-five procedures where the spatial tracking 
accuracy was 3.1 ± 2.1 mm [56]. The tracking accuracy was sufficient enough to perform the 
needle intervention successfully during the biopsy and RF ablation. 
 
Figure 3.9: (A) A common EM tracking procedure with the tracking workstation and a US  
machine for prostate biopsies, (B) EM field generator (circled in blue near the top center of 
image) is placed close to the target and the fiducial patches (yellow arrow in center of image) 
[61]. Used with permission. 
EMTS was also used in guiding the needle tip precisely to the liver tumor without using any 
conventional real-time imaging modality [62, 63]. The EM system can track a 5 DOF small 
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sensor embedded in a needle tip. A point-based registration was performed by obtaining the 
position of the skin fiducial markers, by touching each fiducial with the needle tip, and selecting 
the corresponding position in the preoperative CT data slices. The experiment was performed on 
a physiological respiratory liver phantom model containing a motion simulator, and then on a 
Yorkshire swine's liver where radio-opaque agar nodules were injected as the targeted tumors. 
However, in order to track the target's motion, a separate reference needle was embedded in the 
anatomic region of interest [62, 63]. For some laparoscopic RFA studies, a 3D US image was 
generated from a sweep of 2D US images. The 2D images were obtained from a conventional 
laparoscopic US probe integrated with an EM navigation system [64, 65]. A similar study was 
performed for microwave ablation using NDI Aurora EMTS in [66]. 
In another microwave ablation study, Sindram et al. developed a 3D US guidance system for the 
open hepatic microwave ablation procedure using a computer-based image guidance system, 
InVision™ System (InnerOptic Technology, Inc., Hillsborough, NC, USA) [59]. The system was 
integrated with an NDI infrared OPTS to follow the position of the US handpiece and the 
ablation antenna in real-time. The guidance system was assessed initially on an agar phantom, 
followed by an eight-patient pilot trial. However, due to the ablation "line-of-sight" problem, the 
operators were faced with problems in three out of eight patients, causing difficulty with hand 
positioning that made the actual task of ablation complex [59]. This limitation was overcome by 
incorporating an EMTS (e.g. NDI Aurora), the use of which expanded later in the laparoscopic 
setting [67]. 
Some other commercial systems based on EM tracking technology were also developed for 
percutaneous puncture in the liver; for example, US-guided Ultraguide system (Ultraguide Ltd., 
Yokneam, Israel) [68] and the CT-guided Magellan system (Biosense Webster Inc., Diamond 
Bar, CA, USA) [69]. However, none of these systems gained popularity, possibly due to the lack 
of robustness of their EM tracking technology. The Cappa C-Nav (Siemens AG, Erlangen, 
Germany) has been used for needle puncture in the liver [56], but has recently stopped using EM 
tracking, relying instead on image-based tracking. 
3.1.2.5 Advantages of EMTS 
The main advantage of EMTS is that unlike OPTS, it does not require a direct line of sight 
between the field generator and the sensors. Additionally, miniaturization of electromagnetic 
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sensors (diameters of 5-DOF and 6-DOF sensors are 0.3 and 0.9 mm, respectively) allows them 
to be easily integrated in tools facilitating tracking of rigid or flexible instruments in minimally 
invasive applications. Furthermore, EMTS can track more than one sensor (four 6-D or eight 5-D 
sensors) simultaneously. It is, therefore, possible to reconstruct the shape of flexible instruments 
(such as catheters or bendable needles) by incorporating a series of sensors inside the tool. 
Finally, because of their miniature size, EM sensors at the needle tip can be placed close to the 
target, which lowers the chance of tracking error. In a controlled distortion-free environment the 
tracking error in EMTS is around 1.2 mm [55]. 
3.1.2.6 Disadvantages of EMTS 
The major limitation of EMTS is its susceptibility to magnetic field distortions induced by any 
nearby ferromagnetic materials such as a metallic operation table, pacemakers, or any large 
medical devices (for example, MRI scanners). In such a case, the accuracy may deteriorate 
dramatically with tracking error up to 7.6 mm [70, 71]. It is, therefore, essential to verify the 
accuracy of the EMTS before starting a procedure, especially in a new clinical environment that 
obviously causes a long setup time in clinical practice.  
Compared to OTS, EMTS has less tracking accuracy and lower working volume (only 50-70 
mm
3
).  NDI, the principal manufacturer of both EMTS and OTS, has evaluated the accuracy of 
both systems, particularly of the Polaris optical and Aurora EM tracking systems. According to 
their study, Aurora EMTS has higher positional accuracy error (1.40 mm) with higher precision 
error (0.70 mm) compared to Polaris OTS (0.50 mm and 0.25 mm, respectively) [72]. Another 
technical study compared the same NDI products and found similar results with four times higher 
positional error in EM tracking than in optical tracking [73].  
For more reliable measurements, the field generator of EMTS needs to be placed very close to the 
patient, thereby reducing the size of the tracking volume. Another factor is the orientation of the 
EM sensor (whether it is pointing to or away from the field generator) that determines its 
accuracy. EM sensors are also fragile and more expensive than OTS markers. Frequent usage is 
not ideal, as these are usually embedded in clinical tools and are tethered by wires to the system 
control unit. 
28 
 
3.2 MRI guided interventional procedure 
MR imaging during interventions are primarily used for target definition due to its high soft-
tissue contrast and great resolution enabling excellent visualization of small liver tumors or 
anatomical structures adjacent to the target tissue even without the use of any contrast medium. 
Moreover, because of the ability to guide the needle placement using angiographic sequences 
with freely selectable slice angulations, MRI guided interventions are becoming increasingly 
attractive. An additional advantage is the precise differentiation between living tumor tissue and 
tissue with induced coagulation (due to thermal damage). In fact, the entire thermoablative 
therapy can be planned, guided, and controlled by MRI. But a dynamic, diffusion weighted and 
contrast MR is needed to diagnose tumors first and then to assess tumor ablation and any viable 
tumor post RFA application.  
3.2.1 MRI guided needle interventions 
Depending on the tracking technique, MRI guided needle tracking can be divided into two 
categories: passive and active. The passive tracking method is the traditional technique. Similar 
to X-ray guided procedures, MRI is used to guide the needle. Due to the signal void or 
susceptibility artifacts created by the needle body, the needle appears black in the MR image that 
makes it identifiable on the image for tracking. As this tracking technique is completely based on 
the MR imaging system, no hardware or software modification is required. However, tracking 
information is updated by the temporal frequency of MRI (image acquisition) which is low and 
does not allow real time tracking. MRI temporal frequency can be increased by sacrificing image 
resolution but it makes needle tracking problematic due to low contrast of the needle with its 
surrounding soft tissues. Another limitation of this tracking technique is the requirement of a 
priori knowledge of the needle position to define the MRI scan plane. If the needle deviates from 
the scan plane due to bending, manual repositioning of the scan plane must be performed, which 
makes the procedure time consuming. Moreover, the size and appearance of the artifact are 
greatly affected by MRI sequence parameters and other factors. For example, the orientation of 
the needle with respect to the MRI main magnetic field determines the artifact's characteristics. 
Unlike passive needle visualization methods, active MRI needle tracking is an independent MRI 
procedure by itself and is separate from the regular MR imaging scheme. Therefore, optimization 
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of active needle tracking can be performed without affecting the MR imaging scheme. However, 
modification to the needle and also the MRI system is required for this method. Active needle 
tracking is based on either the enhancement of the contrast between the needle and its 
surroundings or by defining the MR scan plane to follow the needle insertion (Table 3.1). In the 
former method, the needle incorporates a loop wire, through which a weak current is introduced 
that induces a local distortion of the magnetic field. When the needle is placed in the main 
magnetic field of the MRI, the homogeneity of the magnetic field is perturbed, thus making the 
needle appear dark in the image. Though this technique looks similar to the passive tracking 
method, adjusting the applied current in this approach can control the extent the artifacts. 
However, a priori knowledge of the needle position to define the MR scan plane (i.e. similar to 
the passive tracking method) is required. Furthermore, the projection image obtained from this 
wire cannot be used to view the needle because of low contrast between the needle and its 
surrounding tissues; therefore, typical MR imaging sequences are used in addition. The latter 
active tracking method defines the MR scan plane using either an external system (e.g. optical 
stereotactic system) or a micro-RF coil integrated internally into the needle. The working 
principle of the optical stereotactic system, as well as its pros and cons were discussed in section 
3.1.1. From the previous discussion, it is clear that optical stereotactic systems cannot track the 
tip of a needle while it is bent inside the patient. Furthermore, the coordinate space of the stereo 
system needs to match the MRI coordinate space by registration, causing inevitable computation 
as tracking errors. 
 
 
 
 
3
0
 
  
Table 3.1: Classification of MRI guided needle intervention methods with their advantages (light background) and 
disadvantages (deep background) 
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Alternatively, a micro-RF coil (similar to EM sensor) can be integrated into the needle tip and 
followed in MR scanner space directly without doing any coordinate space registration. As a 
result, it is possible to update the MR scan plane according to the tip position. Nevertheless, the 
actual orientation of the entire needle is unknown, which is crucial for navigation.  One option 
could be to follow a pre-defined path computed from preoperative images, but that would not be 
reliable due to the deformation of the liver. Integrating multiple micro-RF coils along the needle 
to calculate the tip and orientation could be an option. However, it is challenging since mutual 
inductance between the coils that are close to each other degrades their performance. Finally, 
electrically conductive leads entering a patient's body cause excessive heating, resulting in burn 
injuries to patients undergoing MR procedures which is a major patient safety concern. 
Alternatively, optical sensing is a more recent technology that can be applied to “sense” the tip 
and orientation of a needle. This thesis work investigates the potential of optical sensing to allow 
active MR needle tracking so that intraoperative needle tracking is possible under simultaneous 
MR image guidance. In the next section, we will discuss the fundamentals of optical sensing 
technology. 
3.3 Optical sensing technology 
The foundation of optical sensing technology is the optical fiber - a flexible, thin and transparent 
strand of silica glass. Optical fibers typically include a transparent core encircled by a transparent 
cladding that in turn is surrounded by a buffer coating (see Figure 3.10).  
 
Figure 3.10: A fiber optic cable containing fiber Bragg gratings. 
The refractive index of the inner core, coren  is higher than the refractive index of the outer 
cladding, cladn . When light is transmitted from the core to the cladding with an angle greater than 
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the critical angle, it causes total internal reflection at the core-cladding interface and keeps the 
propagating light within the core. The outermost buffer coating ensures protection of the fiber 
from the external environment and physical damage. 
3.3.1 Fiber Bragg Gratings 
Due to the photosensitivity of optical fibers, the core refraction index in an optical fiber is altered 
by optical absorption of ultraviolet (UV) light. This allows the fabrication of periodic modulation 
of the refractive index directly into the fiber core, called a Fiber Bragg Grating (FBG). When a 
broad-spectrum light beam is passed through to an FBG, light reflection occurs at each change of 
refractive index. As a result, multiple reflections of the light happen from the repeated 
modulation of the refractive index. At one specific wavelength (called Bragg wavelength), all the 
reflected signals are in phase and interferes constructively to form a back reflected signal to the 
input end. Light reflections occurring at other wavelengths are out of phase, interfere 
destructively, so cancel out each other and as a result are transmitted through the grating. 
Therefore, FBG reflects one specific wavelength and transmits all others (as shown in Figure 
3.11). 
 
Figure 3.11: Principle of fiber Bragg grating sensor [74]. Used with permission. 
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The Bragg wavelength, B is defined as follows [75]: 
      effB n2                  (Eq. 3.1) 
where 
effn is the effective refractive index and   is the period of the gratings. When the period of 
the grating is altered, because of strain or temperature change, the reflected wavelength shifts 
accordingly (Eq. 3.1), which allows the FBG to act as an optical sensor to measure a wide variety 
of parameters, for instance, strain, force, pressure, temperature [76]. 
3.3.2 Application of FBG sensors in the medical field 
FBGs are small in size (around 5 mm), immune to electromagnetic interference and have the 
ability to sense submicron strain. They can be read at high sampling rates (>20 kHz), which is 
sufficient for real-time tracking. These characteristics inspired a wealth of research in various 
medical domains. For example, FBGs have been used for studying the biomechanical behavior of 
the musculoskeletal system, pressure mapping in different orthopedic joints, pressure distribution 
at the intervertebral disc, dental biomechanics, chest wall deformation during respiration, and 
various human-machine interfaces [76]. Due to their immunity to electromagnetic interference, 
FBG sensors are considered a suitable technology to use safely in a high electromagnetic field 
such as in an MRI suite. As a result, applications such as temperature measurement of the patient 
under MRI-guided hyperthermia have exploited FBG sensors [77]. In addition, sensors have also 
been integrated into surgical tools to measure forces in minimally invasive surgeries, such as in 
retinal microsurgery, surgical knots and robotic surgery [77]. The shape estimation of catheters 
and endoscopes using FBG sensors has also been proposed. 
3.3.3 Shape sensing 
One of the advantages of FBG is that it supports optical multiplexing that facilitates the 
integration of more than one FBG sensor in a single fiber and reading each of them. Hence, a 
series of FBG sensors can be placed along a single fiber and then integrated into flexible surgical 
devices such as needles. Recently, FBGs have been applied on biopsy needles, catheters and 
other minimally invasive tools for shape detection and force sensing (e.g. to develop exoskeletal 
robot fingers) [78, 79]. In general, three fibers each with a number of FBGs are glued together to 
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form an equilateral triangle (on transversal plan) and then placed along the device, as shown in 
Figure 3.12. A broadband light source is transmitted through the fibers. When the device bends, 
the fibers also bend. Depending on the bending magnitude and the direction, compression or 
expansion of the FBG sensors occur. Therefore, the period of the grating changes which causes 
the reflected wavelength to shift forward or backward. The amount of the wavelength shift 
directly depends on the amount of the changes in the period of gratings. We describe the working 
principle of shape sensing in Figure 3.12.  
 
Figure 3.12: Application principle of FBG sensors for shape sensing in minimally invasive 
surgical tools. 
We represent the three fibers with three different colors - red, green and blue. There are three 
sensors in each fiber and the sensors are aligned therefore, the cross section of this active area 
contains three FBG sensors. We call this active area a "triplet". In the first active area (i.e. triplet 
#1), the FBG in the green fiber is expanded, that (let us assume) causes the reflected wavelength 
shift in the backward direction. The FBG in the blue fiber does not have any bending effect, so its 
reflected wavelength position is unmoved. However, the FBG in the red fiber is compressed 
which shifts the reflected wavelength in the forward direction. On the other side, we are assuming 
a similar amount of bending in triplet #3 as in triplet #1 but in the opposite direction. As a result, 
the reflected wavelength shift happens in the forward and backward directions for the FBG in the 
35 
 
green and red fibers, respectively. As there is no strain in triplet #2, the reflected wavelength for 
all the three FBG sensors is unchanged. Now, based on the wavelength-shift of the three FBG 
sensors in a triplet, it is possible to calculate the strain and hence, estimate the curvature radius 
and the orientation at that position. Once the curvature information is available at the active 
regions (i.e. triplets), the entire shape can be reconstructed using an interpolation method. 
Recently, using FBG-based shape sensing technology to design minimally invasive surgical tools 
has attracted the attention of researchers. Abayazid et al. [80] used a Nitinol alloy-based flexible 
needle, having a length of 185 mm and diameter of 1 mm with a beveled tip of 30°. The needle 
included FBG sensors at four different locations, each location containing three sensors.  
a
b
 
Figure 3.13: Reconstructed needle shape while the needle was inserted into a soft-tissue phantom, 
(a) top view and (b) side view. Mean tip error for (1) single bend (error 1.5±0.8 mm), (2) double 
bend (error 2.0±0.7 mm), (3) 3D double bend (error 2.1±1.1 mm)  and (4) drilling insertions 
(error 1.7±1.2 mm) [80]. Used with permission. 
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A gelatin-based soft-tissue mimicking phantom was used for the experiment. While the needle 
was inserted into the phantom, the 3D shape of the needle was reconstructed using the FBG 
sensor data. Their reconstructed needle shape was compared with the images obtained from the 
two cameras. We measured a mean tip accuracy of 1.3 mm for 110 mm insertion and 1.8 mm for 
120 mm insertion (see Figure 3.14). 
Park et al. [81] inscribed three fibers with a 120° configuration on the inner stylet of an 18G-150 
mm MRI compatible biopsy needle. Each fiber with a diameter of 250 µm, contained two FBGs 
at 22 mm and 85 mm distance from the base of the needle. They measured tip deflection in two 
orthogonal planes (xy and yz) around the needle axis. For actual tip deflection of ±15 mm, the 
root mean square (RMS) errors for the estimated tip position were 0.38 mm and 0.28 mm in xy 
and xz planes, respectively. 
In another needle shape reconstruction study, Henken et al. estimated the tip position of an 18G-
200 mm long needle. Each of the three fibers contained two FBGs at 56 mm and 126 mm from 
the needle base. A mean accuracy of 0.89 mm (std 0.42 mm) and 1.32 mm (std 0.48 mm) was 
obtained during deflection of the needle tip up to 12.5 mm [82]. In their subsequent work [83], 
they investigated the suitability of FBG-based shape sensing for robotic needle steering by 
simulating extensive error analysis to quantify the accuracy of the needle tip tracking. 
Reza et al. [84] studied real-time 3D shape needle tracking using FBG sensors for teleoperated 
beveled-tip needle steering under MRI guidance. Three fibers were embedded in a similar fashion 
like the previous methods into a 110 mm long and 0.6 mm inner stylet of a 20G MRI-compatible 
biopsy needle. Three FBGs were included in each fiber. The minimum number of sensors and 
their optimal positions in the fibers were studied to keep the needle tip tracking error below 0.5 
mm for various amounts of needle insertion depth. Finally, the reconstructed needle shape was 
visualized in 3D slicer, which is a free open-source software application for medical image 
computing. 
Moore et al. [85] presented a shape sensing method by transforming distributed curvature data 
into a 3D shape by applying elastic rod theory. Their method could be used to estimate the shape 
and location of fiber a such as a catheter in 3D. However, their experimental results show an error 
or 7.2%, most likely due to the twisting of the fiber which was not considered in their method 
[85].  
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Lee et al. [86] developed 3D shape sensing using femtosecond laser direct-written Bragg grating. 
Unlike all the previous methods their sensor configuration did not maintain a 120° angular 
difference between FBG sensors. One waveguide was written at the center of the coreless fiber 
and two additional waveguides were written with a slight offset and parallel with the center 
waveguide. The authors proposed to use the center waveguide, positioned in the fiber's neutral 
axis, for temperature compensation as it should be naturally insensitive to bend-induced strain 
due to its position. Figure 3.15 shows their reconstructed 3D fiber shape for four different shapes, 
including the unstrained straight fiber position (black color).   
 
Figure 3.14: 3D Plot of four different fiber shapes, (a) 3D view of the fiber shapes and three 
corresponding orthogonal views, (b) x-y, (c) x-z, and (d) y-z [86]. The green line segments 
indicate Bragg gratings locations. Used with permission. 
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Another study [87] mainly focused on simulation work to optimize shape sensing. In this study, 
the author developed a simulation tool that can calculate the strain value of the FBGs for a given 
shape. Their simulation tool also showed the reconstructed shape from the strain data. 
3.4 Summary 
Tracking systems are a key component in IGLI, enabling real-time navigation of a needle during 
insertion. Optical and electromagnetic tracking systems are the most commonly used systems 
both in research and clinical settings. However, OTS are not feasible for tracking needle bending 
inside the body and EMTS are not compatible in or near an MR magnet. Therefore, a new 
tracking system that can be easily and reliably integrated into an MRI environment, without 
breaking the clinical workflow, is necessary. FBG sensors have shown huge potential in a limited 
amount of medical applications due to their unique advantages such as small size, high sampling 
rate, immunity to electromagnetic interference and multiplexing capability. It is evident from the 
literature review that the application of FBG sensors in medical device tracking through shape 
sensing has great potential. This technique can have a strong impact on a number of MR 
compatible procedures. 
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CHAPTER 4 METHODOLOGY 
This chapter begins with a complete description of the experimental setup used to design and 
track an interventional needle with shape sensing. The needle fabrication and FBG calibration 
processes are explained, followed by a description of the methodology to reconstruct the shape of 
the needle in 3D. The representation of the reconstructed 3D needle model and the incorporation 
of that model in the preoperative MRI image space are then described. The different steps to 
generate various synthetic phantoms, such as planar and gel phantoms are also demonstrated. 
Finally, a validation scheme to assess the overall tracking accuracy of our FBG-based technique 
is shown. 
4.1 Experimental setup 
Our experimental setup and its individual components are shown in Figure 4.1. Three linear stage 
motors (PM500 stage, Newport Corporation, CA, USA), two arranged for horizontal movements 
(side to side and front to back) and one for vertical movements (Figure 4.1c), were used to 
displace the needle in three different axes. These three motors were assembled and the needle 
was fixed on the topmost motor. A calibration plate (Figure 4.1b) having a series of integrated 
grooves along its edges was used for the calibration procedure. This calibration was to establish 
the relationship between the strain at the sensor locations and the measured wavelength-shift 
values measured from those sensors directly. Contiguous grooves on the calibration phantom, 
spaced at 1.4 mm, were used to hold the tip of the needle at fixed positions during measurement. 
The other end of the needle (i.e. the base) was fixed with a strong spring metal alligator clip. The 
fabricated fibers (illustrated in section 4.2) were placed inside a needle and were clamped near 
the base of the needle to restrict any unwanted rotation or twist. The fibers were connected to an 
interrogator (Deminsys© Python 850-55 interrogator, Technobis, Uitgeest, Netherlands), which 
in turn was linked to a computer by an Ethernet connector. Deminsys© Python has four channels 
and each channel typically supports eight sensors for the interrogation of signals up to 20kHz. In 
our setup, the acquisition data from the interrogator were transferred to the computer using the 
UDP-protocol. In addition, two linear manual stages (Figure 4.1d) were used to adjust the 
position of the calibration phantom in both xy  and xz  planes during the calibration process. Two 
40 
 
cameras (Figure 4.1e and 4.1f) were incorporated to capture the top and side views of the needle 
simultaneously during the experiment. 
 
Figure 4.1: (a) The complete experimental setup of our FBG-based tracking system, (b) 
calibration plate holding the needle tip inside a groove, (c) three Newport PM500 linear stages, 
(d) two manual linear stages, (e) camera-1 and (f) camera-2. 
4.2 Needle fabrication 
The proposed needle integrates FBG sensors made by a periodical modification of the fiber’s 
refractive index, giving an increase in reflection for a specific wavelength. When strain is applied 
along the fiber axis, the period of the grating is changed, leading to a frequency shift in the 
reflected wavelength. It is thus possible to build a 3D shape reconstruction system, modeling the 
fiber in 3D space using several triplets, each made of three FBG sensors separated by 120° as 
shown in Figure 4.2.  This will be explained in the following sections. 
The typical setup uses a broadband laser source to guide light in the fibers. When the fiber bends 
(for example, at triplet #3 as shown in Figure 4.2), FBG sensors are either stretched or 
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compressed, leading to a shift in their reflection spectrum toward longer or smaller wavelengths, 
respectively. 
 
Figure 4.2: 3D shape reconstruction of a needle using the shape sensing technique where bending 
is characterized by the wavelength shift. The left side of the Figure shows the orientation of three 
FBGs at one triplet. The shift of the wavelengths λ7, λ8, λ9 occurs due to the bending at triplet #3, 
while the wavelengths λ1...λ6 remain fixed as no bending takes place at triplets #1 and #2 [88]. 
If there is no bending in the sensing area (e.g. at the locations of triplets #1 and #2), the reflection 
spectrum of all FBG sensors remains unchanged. A spectrometer is connected to the fibers to 
analyze the reflection spectrum of all the nine FBGs in real-time. Knowing the magnitude of the 
spectra’s shift, the curvature radius and the orientation of the fibers triplet can be deduced easily. 
Finally, interpolation is applied on the curvature and its directional data is used to estimate the 
entire 3D shape along with the tip position. 
In our system, three fibers were glued together and integrated into a 150 mm long needle with a 
0.603 mm inner diameter (20G Kimberly-Clark Chiba Spinal Needle), as shown in Figure 4.3. 
The diameter of each fiber was 125 µm and the distance between each fiber core to the center of 
the fiber triplet was ~72.17 µm (i.e. 125/√3). Therefore, the outer diameter of a fiber triplet prior 
to gluing was ~134.67 µm (i.e. 72.17+125/2). 
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Three fibers 
glued together
Needle
 
Figure 4.3: Image shows a 20G Spinal needle and three fibers glued together. Each fiber includes 
three FBGs triplets. 
We requested the Advanced Photonics Concepts Laboratory (APCL) of Polytechnique Montreal, 
Montreal, Canada for fabricating three fibers and glueing them according to our desired 
specification. This lab fabricated FBGs in optical fibers and glued them together using UV curing 
glue maintaining an angular distance of 120° between each other as shown in Figure 4.4.  Each 
fiber contained three FBGs located at 35 mm, 75 mm and 115 mm distance from the needle base 
where the Bragg wavelengths are (~843.3, ~847.8, ~854.3 nm), (~844.1, ~847.7, ~853.9 nm) and 
(~844.6, ~847.9, ~853.8 nm), respectively. Figure 4.4 shows the configuration of the fibers with 
FBGs inside the needle. All the three fibers were connected to the Deminsys© Python 
interrogator through three individual channels. 
 
Figure 4.4: A FBG-based needle with three optical fibers having a 120° configuration. Each fiber 
has 3 FBGs placed at three different locations (35, 75 and 115 mm) along the needle shaft. 
4.3 Acquiring sensor data from the Deminsys© interrogator 
In order to transmit the sensor data directly from the Deminsys© interrogator to a local computer, 
we proceeded with the manufacturer’s instructions as follows. First, a connection was made 
between the computer and the Deminsys system using an Ethernet connector and then by 
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selecting the proper Internet protocol (IP) address from the properties of the Ethernet connection 
of that computer. This enabled us to communicate with the Deminsys system from the computer 
through a web server. We then turned on three superluminescent LEDs (SLEDs) in the 
interrogator. These three SLEDs sent high power density light through the three fibers connected 
to the interrogator by three individual channels.  
 
Figure 4.5: Web server showing the acquisition settings and acquisition control interface. 
Once the SLEDs were activated, we also set the acquisition parameters such as: (i) the total 
number of FBG sensors (i.e. 9 in our setup), (ii) the threshold value to detect the sensor signals 
that depends on the quality of the used FBG sensors and their reflected light intensity (i.e. 800 for 
our FBG sensors), (iii) the downsampling factor (i.e. 1 in our setup) that defines the sample-rate 
as the acquisition data appears at the host and (iv) the packing factor (i.e. 1 in our setup) that 
allows the UDP data payload to be sent in a more bandwidth effective manner, as shown in 
Figure 4.5. Once all the acquisition parameter values were assigned through the web server 
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interface, we started the acquisition by selecting the sensor data option in the acquisition control 
interface. 
The interrogator continuously sends the sensor data to the computer as a series of UDP payload 
packets. It is crucial to understand the structure of the UDP packet payload in order to extract the 
specific information related to the wavelength data. The structure of the payload has four main 
sections, as shown in Figure 4.6. "Protocol_ID" is the first section providing the protocol version 
number. The second section is "Generic_Section" giving the general information about the 
interrogator such as the version, type and identifying number of the interrogator. The specific 
data format, which is defined in the packet is indicated by "Data_Protocol_ID". Finally, the last 
section "Data_Section" contains the sync input and the sensor data. As we were interested in the 
sensor data, we skipped the first three sections and parsed the sensor data. To do that, we had to 
develop an application in Matlab to acquire UDP packets and extract the wavelength data from 
each packet. 
Payload
Data_Protocol_IDGeneric_SectionProtocol_ID Data_Section
Sync_Data Sensor_Data
 
Figure 4.6: The overall structure of a UDP packet payload provided by the Deminsys 
interrogator. 
4.4 Calibration procedure 
From the Deminsys© interrogator, the wavelength data of the three FBG sensors in a triplet 
location was retrieved. The strain value at a triplet location of the needle was estimated by 
performing a calibration procedure. From this strain value it is possible to calculate the curvature 
at that triplet location. The proposed calibration procedure for the needle determines the strain 
value at each FBG sensor location along the needle according to the observed wavelength shift 
values of the corresponding sensor. The calibration matrix at a location 
lx  along the needle is 
defined in Eq. 4.1, where  lxy x  and  lxz x  represents the strain in xy  and xz  planes, 
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respectively,  3,2,1 fbg  represents the wavelength-shift and iC  values of the calibration 
matrix: 
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 (Eq. 4.1) 
According to [74], we can define the strain,  lxy x  at location lx  in y-direction (similarly, in z-
direction) as a function of 
lx :  
  
 
3
3
L
xLyd
x llxy

  (Eq. 4.2) 
where, d  is the distance between the fiber center and the needle center and L  is the needle 
length. We calculated  lxy x  for different known deflections y(L) = (1.4,2.8,...,14 mm) of the 
needle tip by placing the tip in the grooves of the calibration phantom (as shown in Figure 4.7), 
and simultaneously retrieving the corresponding wavelength shift 
fbg  from the Deminsys© 
interrogator.  
 
Figure 4.7: During the calibration procedure, the needle tip is stabilized inside the grooves (a) 
without bending and (b) with bending for a known amount of displacement of the needle tip. The 
distance between the successive grooves was 1.4 mm. 
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Finally, the calibration matrix component  xyC fbg  was found as the slope of the fitting line 
between  lxy x  and fbg  using the least square method. Similarly, we computed  xzC fbg  for 
the xz  plane. 
4.5 Needle shape reconstruction 
Once the calibration matrix was calculated, its inverse matrix was multiplied with the shifted 
wavelengths of the FBGs in a triplet in order to generate the strain values at each triplet location. 
Assuming the needle behaves as a cylindrical rod under pure bending, we can get the curvature 
from the strain as follows: 
 dy xy  (Eq. 4.3) 
where d  is the distance from the fiber center to the core of the needle. Considering our needle 
configuration, the second derivatives at four different locations (three FBGs positions and the tip 
where the strain was zero) were known. Therefore, it was possible to fit a third order polynomial 
along the needle as follows: 
 ylylylyl DxCxBxAxy 
23
)(
 
(Eq. 4.4) 
Polynomial coefficients  yyyy DCBA ,,,  were calculated by solving the following system of 
equations: 
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 (Eq. 4.5) 
The approximated needle profile was obtained by performing a double-integration of Eq. 4.4, so 
that y coordinates along the needle were given as follows: 
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xy   (Eq. 4.6) 
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The same procedure was used to find  lApprox xz . 
4.6 Navigation software 
Once the shape of the needle is reconstructed, it is represented in the coordinate system of the 
FBG interrogator. However, it is not enough to simply infer the 3D shape of a needle in real-time 
and view the shape in an arbitrary space. For real-time image-based navigation, the reconstructed 
needle shape needs to be superimposed on the preoperative image space. Towards this end, a 
fiducial-based registration was performed in order to align the FBG-based tracking space with the 
preoperative image space from a CT or MRI. 
4.6.1 Real-time visualization of needle profile 
For real-time visualization, the following procedure was employed, which required the 
development of a number of software tools to streamline the process prior to needle guidance. To 
begin with, as previously stated, a function was developed in MATLAB (R2013b) in order to 
process the raw UDP packets acquired from the interrogator to extract the wavelength data.  The 
calibration matrix between the shifted wavelength and the strain was generated (according to 
section 4.2) and stored locally on a PC, which was used later for rendering the needle profile in 
real-time (as described in section 4.3). The estimated needle profile values in MATLAB were 
transferred to 3D Slicer for navigation. 3D Slicer (Slicer) is free and open source software that 
can be easily configured to one’s own application. We developed a module and integrated that 
into Slicer for visualizing the needle shape. The connection between MATLAB and Slicer was 
possible using the OpenIGTLink library, another free open-source library for communication 
among devices and software. The whole data flow from the FBG data acquisition to the shape 
sensing visualization in real-time is shown in Figure 4.8. 
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Figure 4.8: Data flow from FBG data acquisition to visualization of shape sensing in real-time. 
4.6.2 3D Model generation 
We created various calibration objects and planar phantoms for validation purposes. In addition, a 
gel phantom containing different tube orientations was made for the in-vitro experiments. 
4.6.2.1 Planar phantoms 
In order to fabricate the planar phantom, a 3D model of the phantom was initially designed in 
SketchUp (www.sketchup.com), a free 3D modeling computer program. Later, the model was 
loaded into a CNC milling machine for the fabrication. The models had a series of grooves just 
big enough to hold the needle tip tightly. The calibration phantom was made of acrylic glass with 
grooves spaced 1.4 mm apart (Figure 4.9(a)), while a copper metal based phantom having 
grooves spaced at 2.67 mm ((i.e. phantom-1 as shown in Figure 4.9(b)) was fabricated to validate 
the needle tip accuracy of our FBG-based tracking system. 
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Figure 4.9: Fabricated planar phantoms, (a) calibration phantom, and (b) validation phantom. 
4.6.2.2 Anatomical gel phantom 
The gel phantom consisted of four transparent silica tubes and polydimethylsiloxane (PDMS) 
elastomer (Sylgard 184, Dow Corning Corporation, Midland, Michigan, USA). The PDMS 
elastomer itself had two components: an elastomer base and an elastomer curing agent. At the 
beginning, a small plastic pot was chosen in which four holes were created. Then, one end of the 
silica tubes was fixed inside the holes and the other end was placed within the pot following 
different orientations. The tubes (inner diameter of 1.58 mm) were oriented in different directions 
so that it was possible to guide the needle (outer diameter of 0.9 mm) inside the tube and bend it 
accordingly to assess tracking curvature. PDMS elastomer was used as a medium to keep the 
tubes' orientation stable. The medium was prepared by thoroughly mixing the base and the curing 
agent in a ratio of 10:1 and then poured inside the pot to cover all the tubes. Since the mixture 
had a significant quantity of air bubbles that could cause artifacts in MRI images, degassing was 
performed by placing the mixture in a vacuum degassing oven for a couple of hours. When all the 
bubbles disappeared, the oven temperature was set to 60°C for one hour. Then the mixture 
became solid and the phantom was ready for the experiment. Six multi-modality radiology 
markers (IZI Medical Products, Maryland, USA) were placed facing the needle entry point so 
that it was possible to touch the markers' center point with the needle tip. Finally, MRI images of 
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the gel phantom were acquired from a 3T clinical MR scanner available at Centre hospitalier de 
l'Université de Montréal (CHUM), Montreal, QC, Canada. 
In order to generate a model from the MRI image volume, a simple thresholding was first applied 
to extract the tube structures. Then, a 3D surface model was constructed from the segmented 
image data by applying marching cubes algorithm [89]. The model was further improved and 
smoothed to generate a continuous 3D shape model. Figure 4.10 shows the original gel phantom 
and the generated model from the MRI image. 
Side View
Top View
ba
 
Figure 4.10: (a) Original gel phantom and (b) the generated model from the preoperative MRI 
image. 
4.6.3 Robotic system for needle translation 
We assembled three Newport PM500 linear stages on a flat metal tool board. As the accuracy of 
the PM500 stage greatly depends on the smoothness of the surface beneath, great care was taken 
when mounting the stages on the board. At first, any remaining dirt, dust or hard spots that might 
hinder the smoothness of the surface were removed from the board. We started by rubbing the 
surface with an Indian oil stone and then gently placed the stages on the cleaned surface. Two 
horizontal PM500 stages were arranged, one on top of the other, where the bottom stage moved 
front-to-back and the upper stage moved side-to-side. One vertical linear stage was then placed 
on top of the horizontal stages to move up and down. It is important to note that all the three 
stages were attached carefully such that the center of mass of all the three PM500 stages was 
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well-aligned. Figure 4.11 shows the various parts of our robotic system that was used for the 
needle translation. 
a
dc
b
 
Figure 4.11: Various parts of the robotic system, (a) vertical and (b) horizontal PM500 linear 
stages; (c) rear side of a controller and (d) National Instruments GPIB-USB-A Controller for 
universal serial bus (USB). Image source from: (a-c) www.newport.com and (d) 
https://www.ni.com. Used with permission. 
All stages were attached firmly with particular care and the weight of the combined load (i.e. 
additional upper stages with cable connectors and needle holder) was supported by the base stage. 
We also left the rear panel of the controller unblocked, in order to allow for air ventilation and 
provide adequate cooling. As suggested in the manufacturer’s reference manual, cables were 
arranged carefully to avoid any disturbance due to tension or friction of the cables during motion. 
In case of an emergency, a Bayonet Neill–Concelman (BNC) connector, next to the cooling fan 
of the controller, was set up to shut down the whole system instantly.   
In the reference manual, two communication interfaces were recommended: RS-232 and general 
purpose interface bus (GPIB). There are some advantages of GPIB over an RS-232 interface such 
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as providing more speed, capability to handle more than one instrument per GPIB controller card 
and an advanced synchronization ability [90]. In our robotic setup for needle translation, a 
computer was connected to the PM500 system by a GPIB-USB-HS (IEEE 488) interface adapter 
from National Instruments (NI), Austin, Texas, USA (as shown in Figure 4.11d). Furthermore, a 
software driver from NI to support GPIB-USB-HS was installed on the computer. MATLAB can 
support the GPIB interface through its "Instrument Control Toolbox". We developed an 
application in Matlab to control the whole PM500 system from a computer. The application 
allowed us to move the needle in three different directions and send the current combined 
translation of the needle from its initial position to Slicer. This translation information was used 
to update the reconstructed needle shape model in Slicer. Figure 4.12 shows the flow of 
commands sent to the PM500 system from a computer and data received from a PM500 system 
by the computer through a GPIB port via standard IEEE-488 cables. 
Combined 3 linear stages
GPIB controller for USB
Controller with a standard IEEE 488 cable
Data
Command
 
Figure 4.12: Illustration of the communication between the PM500 system and a computer. 
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4.6.4 Point-based registration 
In order to represent the 3D reconstructed needle shape in correspondence with the preoperative 
MRI image space including the phantom, a phantom-to-image registration was developed to 
register both coordinate systems. Registration describes the mathematical relationship between 
two spaces to align one space to another. When this mathematical relationship is represented by 
using a 44  homogeneous matrix containing 3D rotation and 3D translation together - the 
registration is called, “rigid”. Among the various rigid registration methods, point-based 
registration is the most popular for IGI. The main reason of its popularity stems from its closed 
form solution when a point set in the source space and its corresponding point set in the target 
space are given. The point set can be obtained by identifying landmarks from the anatomical 
structures of the patient (e.g. grooves of the phantom for our in-vitro experiment) or directly from 
the fiducial markers placed on a patient (e.g. skin markers fixed to our gel phantom). The main 
benefits of the fiducial marker-based approach over anatomical landmarks are the ability to select 
any number of points in any orientation, higher accuracy of point localization and ease of 
establishing the point correspondences. 
 
Figure 4.13: Six multi-modality radiology disk-shaped markers used for the point-based 
registration. 
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We used a 3D model of the planar validation phantom (as shown before, in Figure 4.6b) and a 
preoperative MRI image of the PDMS gel phantom for our in-vitro experiments. For the gel 
phantom, a set of multi-modality radiology markers (IZI Medical Products, Maryland, USA) was 
used as the fiducials for registration (see Figure 4.13). 
To perform the experiment with the gel phantom,  we loaded the preoperative MRI image of the 
phantom within the Slicer environment. The MRI image was in "Digital imaging and 
communications in medicine" (DICOM) format, a standard in medical imaging. Then, we 
searched for the multi-modality radiology markers in the MRI image slices and carefully placed 
fiducials at the center of the marker's position, as shown in Figure 4.14. 
 
Figure 4.14: In Slicer, fiducial points were selected at the center of the multi-modality radiology 
disk-shaped markers visible in the MRI DICOM images. 
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Once the fiducials were selected in the image space, the 3D positions were stored locally on the 
PC in order to perform the registration afterward. During the registration procedure, the positions 
of the fiducials in the physical space were obtained by placing the tip of the needle at the center 
of the markers and recording the needle tip. Accurate needle placement was achieved by using 
our robotic system for needle translation.  
On the other hand, to perform point-based registration using the planar phantom, we began by 
loading the 3D model of the phantom in Slicer. We then placed the fiducials at several easily 
identifiable locations (such as grooves or corners) of the phantom. These fiducials' position (as 
shown in Figure 4.15) were saved and used repetitively during subsequent registration 
procedures. Similar to the experiment with the gel phantom, the corresponding fiducials' 
locations in the physical space were acquired by touching these positions with the tip of the 
needle. 
 
Figure 4.15: Several landmarks such as grooves and corners were selected as the fiducials. 
Once a set of fiducial points is defined in both the image and physical spaces, point-based 
registration was performed to find a rigid transformation from one space to the other. Let us now 
describe the steps of the point-based rigid registration algorithm. For the sake of simplicity, we 
can represent the fiducials in physical space and image space as P  and I , respectively, while N  
is the total number of fiducials in each coordinate system. The measurement of fiducial locations 
in each coordinate system contains some errors. If we assume errors are isotropic, identical and 
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symmetric random noise for all the fiducials, then the unknown transformation can be calculated 
by finding the rotation R and the translation T  that minimizes the error. Therefore, the 
registration problem can be formulated as follows [91]: 
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The translation T  can be defined as PRIT  . To find R . Initially, we need to subtract the 
mean from every fiducial position in each space. So, we get PPP ii 
~
and III ii 
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where the 
centroid of the fiducials is the same in both spaces. This allows expressing Eq. 4.7 as follows: 
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Eq. 4.8 can be equivalently rewritten as the maximum of similarity: 
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which can also be written using the trace of the covariance matrix, 
TIPR
~~
 as follows: 
   TIPRtrace ~~max  (Eq. 4.10) 
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According to the singular value decomposition (SVD) theorem, the square matrix 
TIP
~~
 can be 
represented by the product of three matrices: two orthonormal matrices VU , and a diagonal 
matrix : 
 TT VUIP 
~~
 (Eq. 4.11) 
where VVUU
TT   is the identity matrix,  321 ,, diag  and the eigenvalues 321 ,,  are 
non-negative. Finally, the rotation R  that maximizes the trace (in Eq. 4.10) and minimizes the 
error (in Eq. 4.7) can be found as: 
   
TUVUdiagVR det,1,1  (Eq. 4.12) 
More detailed explanations of this method can be found in [91]. The complete implementation of 
the point-based registration algorithm is built in Slicer as a module named, "Fiducial 
Registration". In our project, we used this module to perform the registration. 
4.7 Validation methodology 
As we can see, the registration step is important for any IGI system to match the physical space 
with the image space. Therefore, the quality of the registration must be determined before 
beginning an intervention. In general, any non-zero displacement (typically, represented as the 
root mean square (RMS) distance) between a transformed point from physical to image space and 
the corresponding point in image space is considered as the registration error. Fiducial 
registration error (FRE) is a commonly used indicator of registration accuracy. FRE is defined as 
(according to Eq. 4.13) the RMS distance between the corresponding fiducials in physical and 
image space after the registration: 
   
N
i
ii yy
N
FRE ˆ
1
 (Eq. 4.13) 
where 
iyˆ  is the transformed fiducial location from the physical space to image space, iy  is the 
corresponding fiducial location in the image space and N  is the total number of fiducial points 
used for the registration. A high FRE indicates a poor alignment between the coordinate spaces, 
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whereas a low FRE indicates a better matching between them. However, a low FRE does not 
always imply a truly accurate registration. Therefore, target registration error (TRE) should also 
be considered that can better represent the accuracy of the given registration by showing the 
actual uncertainty at the point of interest. Registration with low FRE cannot ensure a low TRE 
and vice versa [92]. The TRE can be calculated similarly to FRE, as the RMS distance between 
corresponding points (i.e. targets) other than fiducials in physical space and image space. 
Generally, a few factors such as the number of fiducials and their configuration relative to the 
target are considered to improve the accuracy of the registration. In this project, both FRE and 
TRE were calculated for all the in-vitro experiments. 
4.8 Summary 
In this chapter, we described the entire experimental setup for this project, as well as the 
fabrication process of the needle and various phantoms used for validation. Moreover, the 
calibration procedure was illustrated, followed by a description of the needle 3D shape 
reconstruction methodology. The data flow from the FBG data acquisition to the visualization of 
the 3D shape-sensing needle in Slicer was also demonstrated. Finally, this section concluded with 
the description of the validation technique employed in this project. In the next section, we will 
present the experimental results using the methods described here. 
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CHAPTER 5 RESULTS 
During RFA interventions, the needle shape and the tip position need to be displayed in real-time 
with respect to the preoperative image of the patient, along with the selected target. The overlay 
of the needle shape helps the interventional radiologist to guide the needle tip precisely to the 
target. In this chapter, we represent the results evaluating various components of the proposed 
system. First, section 5.1 illustrates the reconstructed needle shape in Slicer using our proposed 
calibration procedure. In this project, we used an NDI Aurora EMTS as the state of the art 
tracking system.  Section 5.2 demonstrates the tip position and orientation of a needle tip in Slicer 
when the tip is tracked by the Aurora system. Then, we show the results of all three in-vitro 
experiments performed with our developed FBG-based tracking system in section 5.3, 5.4 and 
5.5 separately. These individual sections also include the results of similar experiments carried 
out with the Aurora EMTS for comparison. Finally, we conclude this chapter by a summary in 
section 5.6.  
5.1 Needle shape representation in Slicer 
In the first set of experiments, we applied our proposed calibration procedure, as described in 
section 4.3.  During the calibration procedure, we calculated the strain from the measured 
wavelength-shift of each FBG sensor for different known deflections of the needle tip. The plot 
in Figure 5.1 shows the relationship between the strain and the wavelength-shift for each sensor 
at one triplet location. We represented this relationship by fitting a line using the least square 
method and then defined the slope of the fitted line as the calibration matrix.  
60 
 
 
Figure 5.1: A line is fitted between the measured wavelength-shift and the strain values 
(calculated from the applied tip bending) to define the calibration matrix. 
In Figure 5.1, the measured values of the wavelength-shift are represented with the '*' symbol, 
whereas the linear fits are shown with the line. It is important to note that bending at any triplet 
causes the wavelength-shift of one or two FBG sensors in one direction and the other FBG 
sensors in the opposite direction. For example, due to bending in the xy  plane, a similar but 
opposite amount of wavelength-shift occurred at sensors #1 and #2 while sensor #3 was 
unaffected. On the other hand, bending in the xz  plane caused the wavelength-shift of sensors #1 
and #2 in the same direction, and an equal amount of wavelength-shift of sensor #3 in the 
opposite direction. 
Afterward, we used the calibration matrices to get the 3D shape information of the needle profile. 
These 3D positions were sent to Slicer using the OpenIGTLink protocol by an OpenIGTLink 
connector named 'Deminsys' (see Figure 5.2). We developed a module in Slicer to represent the 
3D view of our reconstructed needle model. Another OpenIGTLink connector (named 'NewPort') 
was also created to receive the needle translation information for updating the reconstructed 
needle position in Slicer. 
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Figure 5.2: Slicer interface showing the reconstructed needle shape with two OpenIGTLink 
connectors. 
5.2 Connecting NDI Aurora EMTS with Slicer 
In this project, we compared the needle navigation accuracy of developed the FBG-based 
tracking system with the accuracy of the NDI Aurora EMTS in terms FRE and TRE accuracy. To 
perform this experiment, we integrated the Aurora system with our experimental setup, as shown 
in Figure 5.3. The Aurora system included a planar magnetic field (connected to the host 
computer by a USB port) and a Chiba-tip needle (18G/150mm). A 5DOF sensor was integrated 
into the tip of the needle that allowed the needle tip to be tracked during navigation in real-time. 
We installed the NDI toolbox software in the host computer to setup the NDI Aurora tracking 
system for needle tracking. The connection between the Aurora system and Slicer was 
established using the OpenIGTLink protocol. 
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Figure 5.3: Experimental setup with an Aurora NDI EMTS where the field generator was placed 
close to the needle tip. 
Before the experiment, the working environment was carefully tested to ensure there were no 
magnetic field distortions induced by any nearby ferromagnetic materials. We connected the field 
generator with a mounting arm that enabled us to place the field generator at any desired position 
and angulation. This mounting arm also restricted any unwanted movement of the field generator 
and provided reliable data measurements. The field generator was positioned close to the needle 
for tracking the tip precisely anywhere within the experimental volume. It was confirmed by 
moving the needle tip at various positions within the working volume for different orientations of 
the needle, and then checking whether the tip was properly tracked. A tool tracking utility was 
provided with the NDI toolbox that showed the tracking information (i.e. the 3D coordinate and 
orientation of the tip). This tracking utility also defined the characterized measurement volume in 
a graphical window. 
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During the experiment, the movement of either the field generator or the phantom was prohibited 
as the shifting of any of these could cause a misleading navigation of the needle tip. Furthermore, 
all the cables were kept separate from each other without any coiling or bending. Particular care 
was taken to place all the cables aside from the measurement volume as they could produce 
magnetic interference.  
At the beginning of the experiment, we established a connection between the NDI Aurora system 
to Slicer using a software toolkit named, "Plus" [93]. Plus is an open-source software that can 
offer data acquisition from various devices such as tracking devices (e.g. NDI Aurora©), 
ultrasound imaging devices (e.g. Ultrasonix), and video capturing devices (e.g. Epiphan).  
Connector
Tip Connector properties
 
Figure 5.4: Acquiring needle tip tracking information from the NDI Aurora system to Slicer 
through an OpenIGTLink connection. A model in Slicer represents the needle tip with 
orientation. 
First, we launched the Plus application and connected to the NDI Aurora Tracker by providing 
appropriate parameter values through an Extensible Markup Language (XML) file. We defined 
the parameters related to the Aurora system such as the type and ID of the tracker, serial port 
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number and acquisition rate. We also specified the parameters associated with the OpenIGTLink 
connection between Plus and Slicer (for example, port number, the type and name of transmitted 
message). The Plus application transmitted the tracking information (i.e. the 3D coordinate and 
orientation of the needle tip) from the Aurora tracker to Slicer. In Slicer, we created a connection 
through the OpenIGTLinkIF module to receive the transmitted data. As shown in Figure 5.4, the 
connection was built by providing the type (i.e. client) and port number (i.e. the listening port 
number defined in Plus). Once the connector started to receive the tracking data (as a 4x4 
transformation matrix), we represented the 3D view of the needle tip in Slicer using a model. 
5.3 In-vitro experiment with planar phantom-1 
The first in-vitro experiment was performed using a planar phantom having regular grooves 
interleaved at a distance of 2.67 mm (as explained in Chapter 4 in Figure 4.9b). This phantom 
stabilized the needle tip at various deflections in both xy  and xz  planes independently. Prior to 
the experiment, the 3D model of the phantom was loaded in Slicer. The reconstructed shape of 
the needle was then fed to Slicer for visualization. Finally, a point-based registration was 
performed as described in section 4.6.4 to co-align both coordinate systems. Some specific 
grooves and corners of the phantom were used as fiducials for registration. 
We used the "Fiducial Registration" module of Slicer to perform point-based registration. To 
define the input parameters of the algorithm, we selected the fiducials identified in the image or 
phantom model space as the "Fixed landmarks", while the fiducials in the physical space were 
selected as the "Moving landmarks". We obtained a registration matrix as an output of the 
module. The module also displayed the FRE with an output message indicating the quality of the 
registration. Figure 5.5 shows the interface of the "Fiducial Registration" module in Slicer. 
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Figure 5.5: The interface of the module named, 'Fiducial Registration' in Slicer with its input and 
output parameters. 
The interface provides the option to select a different set of fiducials as the input parameters and 
save the output registration matrix with RMS error. After obtaining a 44  homogeneous matrix 
as the registration matrix, we applied that matrix to the reconstructed needle shape to overlay on 
the phantom model. Then, the tip of the needle was placed in different grooves while the 
corresponding position of the tip and the needle shape in Slicer were captured. The needle 
navigation in the physical space was also recorded by the cameras used in our setup. We 
combined these two video sequences together for side-by-side comparison.  Some screenshots of 
the video clip are shown in Figure 5.6. 
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Figure 5.6: Real-time visualization of the reconstructed needle shape in Slicer for various tip 
deflections using the planar phantom-1. 
In Figure 5.6, the left side shows the reconstructed 3D needle shape with its tip position in the 
grooves of the phantom model in Slicer and the right side displays the needle shape with tip 
position in the physical space. It is apparent from these results that for various levels of tip 
deflection, our reconstructed needle model can successfully show the accurate position of the 
needle tip. 
Evaluating the quality of the registration accuracy is essential. One such quantitative measure is 
the fiducial registration error (FRE), as described in section 4.6. In this experiment, the FRE was 
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calculated repetitively using different sets of fiducial point pairs (N=6~8), where the average 
RMS error was found to be 0.54 ± 0.12 mm. 
Another quantitative measure to assess registration accuracy, the target registration error (TRE), 
was calculated to evaluate the registration accuracy at the target location. The tip of the needle 
was placed in different grooves of the phantom, and the corresponding tip position of the needle 
model was recorded in Slicer. Obtaining the position of both the target (i.e. the groove) and the 
corresponding estimated needle tip in Slicer was straightforward and accurate, as it was possible 
to place a small sphere at both the positions in Slicer that showed their 3D coordinates directly. 
The RMS distance between the target and the needle tip was calculated to generate the TRE (as 
illustrated in Figure 5.7). The TRE was calculated at various points of interest of the phantom. 
However, the points that were used to calculate the FRE were not selected for the TRE. 
Tip
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Figure 5.7: TRE is defined as the RMS distance between the actual target location and the 
estimated needle tip position in Slicer. 
Phantom-1 allowed the deflection of the needle tip in both the xy and the xz  plane separately up 
to 10.68 mm from its initial position. Figure 5.8 represents the TRE distribution for the tip 
deflection of ±2.67, ±5.34, ±8.01, ±10.68 mm from its initial position in both the xy and the 
xz direction. The measurements were taken 10 times at different grooves. Analyzing the error 
distribution statistically, we can see in the figure that the RMS error is increasing linearly with 
the amount of tip deflection (i.e. TRE = 0.05*tip_deflection_amount, where 0.05 is the slope). 
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The overall RMS error obtained by our system was 0.96 ± 0.05 mm and 0.95 ± 0.06 mm for a tip 
deflection maximum of 10.68 mm in xy  and xz  plane, respectively.  
 
 
Figure 5.8: Accuracy of the estimated needle tip position of our FBG-based tracking at various 
deflections in both (a) xy  and (b) xz  planes of phantom-1. 
We did the same experiment with the Aurora NDI EMTS. At first, we connected the Aurora 
system to Slicer as described in the previous section 5.2. Once we received the needle tip tracking 
information, then the phantom model was loaded in Slicer. We performed the registration 
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procedure using the similar grooves and the corner points of the phantom. After that, we applied 
the registration matrix on the needle model. We obtained an FRE of 0.49 ± 0.08 mm. The 
registered needle model was overlaid on the phantom-1 model. Then, similar to the experiment 
with the FBG-based tracking system, we placed the tip of the needle at different grooves and the 
corresponding position of the tip in Slicer was captured. We captured the entire needle navigation 
procedure by the cameras. Figure 5.9 shows a side-by-side comparison of the needle navigation 
in Slicer and the physical space. 
 
Figure 5.9: Real-time visualization of the EM-based needle navigation in Slicer for various tip 
deflections using planar phantom-1. 
The left side of Figure 5.9 shows the tip position in the grooves of the phantom model in Slicer 
and the right side displays the corresponding needle shape with tip position in the physical space. 
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We calculated the TRE distribution for the tip deflection of ±2.67, ±5.34, ±8.01, ±10.68 mm from 
its initial position in both xy  and xz direction. Figure 5.10 shows our calculated TRE 
distribution for the Aurora system. The overall mean RMS error obtained by the Aurora system 
was between 0.54~ 0.83 mm and 0.51~0.84 mm for a tip deflection maximum of 10.68 mm in 
xy  and xz  plane, respectively. 
 
Figure 5.10: Accuracy of the estimated needle tip position of the Aurora system at various tip 
deflections in both (a) xy  and (b) xz  planes of phantom-1. 
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We also evaluated the shape accuracy of the reconstructed needle at different tip deflections for 
our developed FBG-based tracking system. In our experimental setup (as shown in chapter 4 in 
Figure 4.1), two cameras were installed that captured the top and the side views of the needle. 
The needle had a series of circular black markers uniformly placed on its shaft. These markers 
were clearly visible in the camera images and easily selected by clicking the mouse pointer on 
them.  
When the needle is not bent, the physical distance between two successive markers is 10 mm, as 
shown in Figure 5.11. A similar equivalent distance between the successive markers was 
obtained from the camera image in a number of pixels, #pixel. Therefore, the physical distance 
between two pixels in the camera image was calculated by dis = 10 mm / #pixels. 
10 mm
Horizontal  AxisOrigin markers
 
Figure 5.11: The markers on the needle shaft were used to find the needle shape from the camera 
images. 
The base of the needle was used as the origin where the straight non-bending needle shaft was 
considered as the horizontal axis. Therefore, the positions of the markers of a non-bending needle 
from its base to the tip direction were [10 mm,0], [20 mm,0],...,[150 mm,0]. For any deflection of 
the tip, the needle shaft was bent, and the markers were displaced from the horizontal axis. This 
displacement for each marker was initially counted in pixels, then converted into a physical 
distance and finally the markers' position was defined from the origin.  
On the other hand, the corresponding position of the markers in the reconstructed needle model 
was obtained directly from our reconstruction algorithm. In Figure 5.12, the plots show the 
theoretical position of the markers (denoted by 'O') that was calculated from the camera images. 
Also, the plots view the experimental position of the marker (denoted by '*') that was 
approximated by our algorithm. The calculated mean RMS error of the entire needle for the 
maximum tip deflection of ±10.68 mm were 1.42 ± 0.21 mm and 1.47 ± 0.19 mm in xy  and 
xz plane, respectively. However, the needle provided with the Aurora system contained a sensor 
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only at the tip. As there was no sensor along the needle shaft, it was not possible to reconstruct 
the actual shape of the needle using the Aurora EMTS. 
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Figure 5.12: Comparison between the physical and approximated needle shape for several 
amounts of tip deflections in the xy  plane. The plots show the position of the markers on the 
needle tip along the y-axis. 
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5.4 In-vitro experiment with planar phantom-2 
We also performed the experiment with a second planar phantom (i.e. phantom-2, see Figure 
5.13), which includes 23 holes that allow deflection of the needle tip in both xy  and xz  planes 
simultaneously at various magnitudes. Phantom-1 allowed deflection of the tip either in xy  or 
xz plane, but phantom-2 ensured the tip deflection in both the xy  and the xz planes at the same 
time. 
 
Figure 5.13: Real-time visualization of the reconstructed needle shape with its tip position in 
Slicer for various amount of tip deflections using planar phantom-2. 
We performed the registration process using the different holes (N=6-8) of the phantom as the 
fiducials. The average FRE was 0.52 ± 0.11 mm. After applying the registration matrix on the 
reconstructed 3D needle shape, the tip of the needle was placed in different holes and the 
corresponding positions were observed in Slicer. The entire experiment was captured by video 
cameras while the needle navigation in Slicer was recorded using a screen capturing software. 
Figure 5.13 shows several side-by-side screenshots showing a real-time visualization of the 
reconstructed needle shape in Slicer for various amounts of tip deflections using the planar 
phantom-2.  
The TRE was calculated in the same fashion as it was done previously with phantom-1. For this 
specific phantom, we deflected the tip of the needle at 2.35, 3.37, 8.05, 8.27, 14.51, 16.67 and 
16.83 mm distances from its initial non-bending position (shown as a black star in Figure 5.14b). 
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Figure 5.14c represents a similar TRE distribution pattern to what was observed in Figure 5.6 for 
phantom-1. It showed a linearly increasing RMS error with the increase in the amount of tip 
deflection (i.e. TRE = 0.07*tip_deflection_amount, where 0.07 is the slope). The overall 
maximum RMS error obtained was approximately 1.05 ± 0.08 mm for a tip deflection maximum 
of 16.82mm. 
 
Figure 5.14: (a) Phantom-2 containing a set of holes and (b) its 3D model, the non-deflected 
needle tip position is shown as a black star, (c) RMS error distribution of the needle tip position 
at various deflections (shown in individual color) for the FBG-based tracking system. 
We calculated the registration accuracy of the Aurora EMTS using phantom-2 in a similar way to 
what was done with the FBG-based system. As phantom-2 was made of metal, to avoid any metal 
interference, we prepared an exact replica of phantom-2 in plastic. This plastic phantom was 
made from a 3D printer. We performed the registration using the similar fiducial points that we 
used for the FBG-based tracking system. The mean RMS registration was of 0.58 ± 0.09 mm. 
Figure 5.15 shows the real-time needle navigation in Slicer using NDI Aurora EMTS. However, 
the model in Slicer only represented the tip of the needle with its orientation and did not describe 
the needle's shape. 
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Figure 5.15: Real-time needle navigation with phantom-2 made in plastic in Slicer using NDI 
Aurora EMTS for various tip deflections. 
We also calculated the TRE for the Aurora system using similar target points to those we 
considered for the FBG-based tracking system. The overall TRE was between 0.59 and 0.89 mm 
for the maximum tip deflection up to 16.82 mm (see Figure 5.16).  
 
Figure 5.16: (a) Phantom-2 made of plastic containing a set of holes and (b) its 3D model, the 
non-deflected needle tip position is shown as a black star, (c) RMS error distribution of the 
needle tip position at various deflections (shown in individual color) for the Aurora EMTS. 
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The TRE error distribution in Figure 5.16c shows a random orientation. The bending of the 
needle tip does not have any effect on the needle tip tracking accuracy. 
5.5 In-vitro experiment with gel phantom 
The last set of in-vitro experiments validating the needle navigation with the shape sensing 
device was done with a tubular gel phantom, as described in section 4.6.2.2. At first, a point-
based registration between the physical space and MRI image space was performed using a set of 
multi-modality radiology markers (N=6), yielding a mean RMS error of 0.84 ± 0.12 mm. Then, 
the 3D model of the gel phantom, which was prepared in advance, was loaded in Slicer. Once the 
registration matrix was applied to the reconstructed needle model, it was possible to navigate the 
needle through the tubes of the gel phantom. The needle navigation through various tubes is 
shown in Figure 5.17, where the reconstructed needle shape is visible inside the segmented tubes. 
However, navigation through one of the tubes was not accomplished, because of an internal 
blockage of the tube by the PDMS mixture. For the other three tubes, we guided the needle tip to 
the end position of the tubes and those end positions were used as the targets to measure TRE. 
The average TRE error calculated for this experiment was 1.19 ± 0.09 mm. 
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Figure 5.17: Needle navigation through various tubes of a gel phantom. The reconstructed needle 
shapes (shown in blue color) were well inside the segmented tubes. 
An in-vitro experiment with the gel phantom was also performed using the Aurora EMTS 
system. Similar to all the previous experiments, as a first step we applied point-based registration 
between the physical space and MRI image space using the same set of multi-modality radiology 
markers. The calculated mean RMS error was 0.81 ± 0.13 mm. Then we imported the 3D 
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segmented model of the gel phantom in Slicer. Needle navigation through the tubes of the gel 
phantom was then performed. Experimental results shown in 5.18 illustrate that the tip of the 
needle model in Slicer was well inside the segmented tubes during the navigation. 
However, navigation through two of the tubes was not accomplished, because of the inside 
blockage of the tube by the PDMS mixture and also for the larger diameter of the 18G EM needle 
(compare to 20G FBG needle). Therefore, the end point of the other two tubes was used as the 
targets. The average TRE error for this experiment was 1.06 ± 0.11 mm. 
 
Figure 5.18: Needle navigation using the Aurora EMTS through different tubes of a gel phantom. 
5.6 Summary 
In this chapter, we first showed the results of the proposed calibration method, followed by a 
representation of the reconstructed 3D needle shape within the Slicer software interface. We 
performed a series of in-vitro experiments to validate our FBG-based tracking system. The results 
obtained from each of the experiments were shown in detail along with the overall registration 
accuracy. In order to compare the tracking accuracy to the state of the art tracking systems, we 
integrated an NDI Aurora EMTS with our experimental setup and performed a series of in-vitro 
experiments. The results obtained from the experiments with the NDI Aurora EMTS were shown 
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to compare favorably with the results achieved by our FBG-based tracking system. In the next 
section, we will discuss and analyze these results and evaluate the system’s limitations. 
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CHAPTER 6 DISCUSSION 
RFA has proven to be an effective percutaneous treatment modality for unresectable hepatic 
tumors in a non-transplant candidate. Typically, a needle is directly inserted into the tumor, 
which in turn delivers radiofrequency energy to cause necrosis of the tumors. Therefore, accurate 
needle tip placement is essential in RFA of liver tumors. In practice however, it is challenging 
due to various factors such as inhomogeneity of the tissue, needle insertion depth and asymmetry 
of the needle tip that cause bending of the needle. As a solution, an intraoperative US image is 
used to guide the needle tip to the target that is defined in the preoperative CT or MRI diagnostic 
image. However, visualization of the target and the needle under US image guidance is 
problematic due to the limited spatial resolution of the US image. Also, thermal ablation 
generates micro-bubbles and shadows that interfere with the visualization. CT can be used as an 
alternative, but generates ionizing radiation to the patient as well as to the clinical operators (e.g. 
the interventional radiologists). On the other hand, needle navigation under MRI guidance is a 
potential alternative due to its angiographic sequences and the ability to freely select the slice 
angulations in the needle plane. Moreover, it can also be used to monitor RFA-induced heating 
and thermal damage of the cancerous tissues. However, the resolution of the image generated 
from angiographic sequences is low compared to that of the diagnostic image obtained from the 
regular MRI imaging sequences. Another major challenge is the scarcity of MRI-compatible 
instruments.  
This thesis focuse on the 3D shape reconstruction of an entire needle in real-time using 
measurement from MR-compatible FBG sensors. The goal was to develop a tracking system that 
could safely track the needle's and the 3D shape in a high EM field during MRI-guided 
interventions for liver tumors. We performed a series of in-vitro experiments with our FBG-based 
tracking system. To compare the tracking accuracy of our system, we performed similar 
experiments with an Aurora EMTS. In section 6.1, we analyze the in-vitro experimental results 
presented in chapter 5. In section 6.2, we discuss the results obtained from other research groups 
who used a similar shape sensing technology to reconstruct the needle shape. Section 6.3 
demonstrates the MRI compatibility of our FBG sensors. Then, the measurement of the 
maximum curvature that is supported by our fiber system is shown in section 6.4. Finally, we 
state the limitations of our system in section 6.5, followed by the summary in section 6.6. 
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6.1 Comparing FBG-based tracking with Aurora EMTS 
In our first in-vitro experiment, we tested the tip tracking accuracy of our FBG tracking system in 
two different orthogonal planes of the needle axis where the TRE was 0.96 ± 0.05 mm and 0.95 ± 
0.06 mm for tip deflection of up to ±10.68 mm in the xy  and xz  planes, respectively. The 
corresponding error for the NDI Aurora system was comparatively lower. The error was between 
0.54~0.83 mm and 0.51~0.84 mm for a tip deflection from ±2.67 to ±10.68 mm in the xy  and 
xz  planes, respectively. By analyzing the RMS error distribution for different tip deflections, we 
can see that as the tip deflection decreases the error of FBG tracking also decreases. On the other 
hand, the error of the Aurora system was similar for different tip deflections.  
However, in this experiment, the FRE of the FBG tracking system (i.e. 0.43 ± 0.12 mm) was 
similar to that of Aurora EMTS (i.e. 0.42 ± 0.10 mm). It is important to mention here that, during 
the registration procedure for both systems, the needle was not bent to collect the fiducial 
markers' position. We utilized our robotic system that translated the needle base to position the 
needle tip at the fiducials' location without inducing any bending. Since fiducial localization error 
due to the bending of the needle was avoided, we achieved a similar FRE for both systems. 
Results obtained from the second in-vitro experiment with phantom-2 showed similar error 
distributions to the previous experiment for the FBG-based tracking system. In this experiment, 
we were interested in deflecting the needle tip further up to 16.83 mm from its initial non-
bending position. For tip deflections of 2.35, 3.37, 8.05, 8.27, 14.51, 16.67 and 16.83 mm from 
the initial non-bending position, the corresponding mean tracking errors were 0.52, 0.59, 0.67, 
0.70, 1.00, 1.05 and 1.05 mm, respectively (as shown in Figure 5.14). We can interpret that the 
error increased linearly as the tip deflection increased. On the other hand, the corresponding 
mean tracking errors for the Aurora system were 0.72, 0.71, 0.67, 0.75, 0.82, 0.78 and 0.76 mm, 
respectively (as shown in Figure 5.16). The errors were similar for all of the tip deflections and 
the small differences in the TRE values may be due to random jitter noise in the Aurora system.  
However, the FRE of the Aurora system for this experiment with phantom-2 was comparatively 
higher than that of our FBG-based tracking system, 0.58 ± 0.09 mm and 0.52 ± 0.11 mm, 
respectively. This is possibly due to the fiducial localization error caused by phantom-2, as the 
holes created from the 3D printer were not smooth and accurate enough (see Figure 6.1). White 
arrows indicate the distorted holes in Figure 6.1(a). 
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Figure 6.1: (a) The plastic model of the phantom-2 where white arrows show the distorted holes. 
(b) 3D model of the phantom-2. 
Unlike the previous two experiments where the needle tip was deflected in free-space, the last in-
vitro experiment was done inside a gel phantom. The tubular structures of the gel phantom forced 
the needle to bend with defined paths while guiding the needle through them. The experimental 
results showed that our FBG-based tracking system successfully tracked the needle tip with its 
3D reconstructed shape. The computed FRE was similar for the two systems, with an RMS error 
of 0.81 ± 0.11 mm and 0.84 ± 0.12 mm for the Aurora EMTS and our FBG-based tracking 
system, respectively. The FRE of both systems in this experiment were relatively higher than that 
of the previous two experiments. Selecting the fiducial position in the planar phantom model was 
comparatively easier than choosing the fiducials in the MRI image. The fiducial localization error 
in the MRI image may have been large, thus degrading the registration accuracy. As a result, the 
TRE was also larger for both tracking techniques in this experiment.  
Both the qualitative and quantitative results obtained from all the in-vitro experiments indicate 
the potential feasibility of FBG-based tracking to follow the needle during RFA of liver tumors. 
The overall maximum tip position error was approximately 1 mm for tip deflections of up to 
16.82 mm. The measurement obtained from the two camera images also confirmed the high 
accuracy of our reconstructed needle shape. It would be interesting to compare the shape of the 
reconstructed needle from both tracking systems; Unfortunately, we could not do this with the 
needle from NDI as it did not have any sensor along its shaft. The sole EM sensor at the tip of the 
needle was connected by wire to the system control unit (SCU) of Aurora. In order to reconstruct 
the shape of the entire needle, a series of EM sensors should be placed along the needle shaft. 
Cables from all of the sensors have to pass through the needle, which might increase the diameter 
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of the needle and make the needle unsuitable for percutaneous interventions. Also, we noticed 
that the tip of the needle was not tracked for some orientations of the needle with respect to the 
field generator. Figure 6.2(a) shows one of the needle orientations (close to perpendicular to the 
field generator) for which the Aurora system did not track the tip. Even though the tip was well 
inside the working volume, the NDI tool could not represent the tip position due to a bad fit, as 
shown in Figure 6.2(b).   
 
Figure 6.2: (a) A needle orientation for which the tip was not tracked by the Aurora system, (b) 
the tip position (indicated by arrows) is shown well inside the working volume in NDI tool 
tracker interface. 
Compared to the EM-based tracking system, the FBG-based tracking system is smaller in size 
(see Figure 6.3). Also, the field generator of an EMTS must be placed close to the target and 
arranged in such a way that the needle tip can be tracked for any orientation of the needle inside 
the working volume. The placement of the field generator sometimes limits the choice of 
orientation for needle insertion. 
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Figure 6.3: Side-by-side physical dimension comparison between a Deminsys© interrogator and 
an Aurora field generator with its system control unit. 
6.2 Comparison with other shape sensing methods 
There are other groups working on the shape sensing methods to reconstruct the needle profile 
[80-82]. Among them, the most promising results were claimed by Park et al. They reported 
RMS errors of 0.28 mm and 0.38 mm for tip deflections of ±15 mm. The main reason behind 
their better result may be because of the choice of the optimal position of the sensors along the 
needle. For different amounts of tip deflection, they calculated the sensors' optimal position that 
generated the least amount of error to estimate the tip position.  
However, it is important to understand what the tip accuracy means in our work. Similar to Park 
et al.'s work, all the other research works show the tip accuracy in the needle space only. They 
did not perform any registration procedure to measure the tip accuracy with respect to the target. 
To the best of our knowledge, this work is the first to show the errors following the typical image 
guidance procedural steps. We performed a point-based registration and then applied the 
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calculated registration matrix on the reconstructed needle shape to overlay it on the targeted 
phantom. After that, we navigated the needle to place the tip to the target defined on the phantom. 
Finally, the RMS distance between the actual target and the estimated tip position was defined as 
the tracking error. 
In our needle configuration, we glued the three fibers together with a UV curing glue and then 
inserted the combined fiber into a 20G needle. The diameter of the combined fiber might not be 
uniform along the needle shaft. Hence there could be a small gap between the needle's inner body 
and the fiber at some points. As a result, during the calibration procedure, while the needle shaft 
was bent by deflecting the tip, the fiber inside might not have bent accordingly. This could have 
contributed cause some error in our experiments. 
Furthermore, it's hard to compare the tip position accuracy for different tip deflections among 
previous shape sensing studies. This is because the factors considered in prior research works are 
different in many ways: the number of sensors used per fiber, the length of the needle and the 
sensor placement along the needle and calibration setup. All previous works are set up in the 
laboratory and none have demonstrated a comparison study of the tracking technologies. In this 
thesis work, we experimentally compared the accuracy of our optical shape sensing based 
tracking system with a state of the art tracking system, the NDI Aurora EMTS. 
6.3 MRI compatibility 
FBG sensors are immune to electromagnetic interference. We performed an experiment to verify 
the MRI compatibility of the FBG sensors of our fiber system. The experiment was done inside 
the bore of a 1.5T MRI scanner (see Figure 6.4). At first, we fixed the fiber on a tray by keeping 
it straight, so that there was no bending along the fiber. Then we took measurements from all the 
FBG sensors outside of the MRI scanning room. We recorded the measurements for at least 5 
seconds. 
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Figure 6.4: Image shows the fibers placed inside the bore of a 1.5T MRI scanner. 
After that, only the fiber was placed inside the MRI bore. The interrogator and the laptop were 
positioned far from the MRI scanner. Then, we recorded the sensor data for another 5 seconds. 
Figure 6.5 shows the calculated wavelength-shift measurement of all the FBG sensors both inside 
and outside the MRI scanner. By comparing the results, we can conclude that there were no 
significant changes in the measured wavelength-shift data generated within the MRI magnetic 
field. The small amount of wavelength-shift for all the sensors, which was visible in both 
scenarios, may be due to the air flow generated by the cooling fan of the electronic machinery 
(e.g. laptop) or any nearby mechanical vibrations. This is because the FBG sensors are very 
sensitive to strain variations and can sense strain at the micron scale. 
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Figure 6.5: The calculated strain of all the FBG sensors both (a) inside and (b) outside the MRI. 
6.4 Maximum curvature supported by our fiber system 
FBG sensors are usually made of glass and are therefore fairly fragile which limits their its 
flexibility. For the shape sensing method, which uses three fibers that are glued together (as we 
did in our work), this further reduces flexibility. We performed an empirical test to verify the 
maximum curvature (i.e. minimum curvature radius) that our fibers can support. We used a 
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cylindrical cone shaped plastic object for this experiment (see Figure 6.6). The diameter of this 
object varies gradually from one end to the other, ranging from 6.2 mm to 30 mm. 
 
Figure 6.6: A cylindrical cone shaped plastic object with an inner diameter ranging from 6.2 mm 
to 30 mm. 
During the experiment, the fibers were bent around the perimeter of the plastic object to make a 
complete loop and the diameter of cross section was measured (see Figure 6.7). We started from 
the end of the plastic object that had the higher diameter (30mm). Each time we completed the 
measurement, we moved the fiber to the next smaller diameter region and repeated these steps 
until the fibers broke. According to this experiment, our fibers supported a maximum curvature 
of ~0.125 mm
-1
 (i.e. minimum curvature radius of ~8 mm).  
 
Figure 6.7: Image shows the curvature measuring experiment where the fibers were wrapped 
around the plastic object. 
90 
 
6.5 Limitations 
One of the limitations of our FBG-based tracking system is that we cannot steer the needle tip in 
a pre-defined direction. We did not implement needle steering as it was considered out of the 
scope of this thesis work. As a solution, we fabricated a gel phantom having some tubular 
structures. These structures allowed us to prepare the trajectory plans in advance. Also, our gel 
phantom, as well as the planar phantoms, ensured allowed the experiments to be performed in a 
controlled environment and in a repeatable manner.   
In contrast to the Aurora EMTS that can track the tip for any needle orientation, in our 
experimental setup, we cannot change the needle orientation. Since the needle profile is 
represented with respect to the base of the needle, all movements from the base should be 
tracked. By using the movement information of the needle base, we can represent the needle 
profile in a global coordinate space. The robotic translation system in our experimental setup 
permits 3D translation of the needle base. It does not allow any angular movement of the needle. 
Furthermore, even though our fiber system and the gel phantom are MRI compatible, the 
calibration setup is not supported by the MRI as it is completely made of metal. For this reason, 
we could not perform the in-vitro experiments inside the MRI scanner.  
6.6 Summary 
By analyzing and interpreting the results obtained from the in-vitro experiments, we can say that 
the accuracy of our FBG-based tracking system is suitable for needle tip detection in RFA of 
liver tumors. The accuracy of our tracking system is comparable to that of an NDI Aurora EMTS. 
We believe that the error linked to tip bending is mainly caused by the misalignment of the three 
FBGs in a single axial plane and also the gap between the needle's inner boundary and the fibers 
inside. In addition, we think that an optimal placement of the sensors along the needle shaft can 
reduce the error by better approximating the shape of the needle. Finally, the experimental results 
prove that our fiber system is MRI compatible and flexible enough to support the needle bending 
required for RFA procedures in the liver. 
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CHAPTER 7 CONCLUSION 
In this thesis, we developed a 3D shape reconstruction technique of needles using FBG sensor 
measurements that made it feasible for tracking the tip and the shape of a needle inside a high 
EM field during MRI-guided needle interventions in the liver. Towards this end, three glass 
fibers equipped with three FBGs were glued together maintaining an angular distance of 120° 
among the fibers which were then incorporated into a 20G needle. We presented a simple and fast 
calibration procedure to get the strain at the sensor location from the measured wavelength-shift 
values. The entire 3D shape of a needle was reconstructed based on polynomial fitting of the 
calculated strain measurements. For visualization, we built a module in 3D Slicer that represented 
the 3D shape of the needle in real-time. A point-based registration algorithm was applied to co-
align the FBG tracking space with the preoperative MRI image space. We validated our FBG-
based needle navigation by doing a series of in-vitro experiments. The measurement information 
obtained from the camera images ensured the shape accuracy of our reconstructed needle. Results 
obtained from a series of in-vitro validation experiments demonstrated needle tip tracking errors 
of 1.05 ± 0.08 mm for a deflection of the needle tip of up to 16.82 mm on a ground-truth model, 
which is appropriate for applications such as RFA of liver tumors. Furthermore, by performing 
identical experiments with an NDI Aurora EMTS that compared the tracking results (i.e. FRE 
and TRE), the feasibility of the FBG-based tracking system for MR guided interventions was 
verified. Positioning error is attributed to the misalignment of the FBG sensors in a single axial 
plane and the gap between the needle's inner boundary and the fibers inside.  
Finally, even though the shape sensing technology based on FBG sensors shows the ability to 
track the needle tip in real-time, it still cannot be used solely during intervention without a pre-
intervention imaging modality. This is because a soft-tissue organ such as the liver deforms 
significantly during an intervention due to patient's breathing and due to the patient being under 
the effect of anesthesia and positioned differently on the surgical table. This deformation is not 
compensated by the FBG tracking system. Therefore, a fast imaging system is a must to know the 
exact position of the target. The imaging system also can confirm the position of the needle with 
respect to the target. MRI is the ideal imaging modality to visualize small tumor as it has high 
soft-tissue contrast and high spatial resolution. Therefore, a preoperative MRI scan with an 
imaging sequence can be acquired just before starting the needle insertion. Next, angiographic 
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MRI image sequences can be used as an intraoperative imaging modality as they have the ability 
to provide fast image information. Since FBG is immune to electromagnetic interference, it is 
possible to perform FBG-based needle interventions under MRI guidance. While the low 
frequency MRI image can accurately visualize the target, the high frequency FBG-based tracking 
system can localize the needle tip position in real-time. Additionally, FBG-based shape sensing 
can define the MRI image plane automatically in real-time. 
In this project, needle steering was not considered. In future work, we would like to integrate a 
robotic steering system with our tracking system. This steering system would allow accurate 
control of the tip placement during insertion. The operator could then adjust the position and 
orientation of the tip intra-procedurally in case there is any change to be made to the needle’s 
trajectory. Thus, retraction and reinsertion of the needle could be avoided. In addition, it might be 
possible to reach multiple targeted locations by a single needle insertion.  
Unlike existing tracking systems, the proposed FBG-based tracking system is the first tracking 
technology which is compatible with MRI and therefore, this technique can have a strong impact 
on a number of MR-compatible procedures including MR-guided hyperthermia, MRI-guided 
biopsies and therapies (e.g. prostate biopsy) and MR navigation of nanoparticles inside the 
capillary network. However, application is fairly recent and was performed only in a research 
setting. Therefore, extensive research and thorough in-vivo experiments are required to 
demonstrate its viability for clinical adoption. 
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